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AIM2-Like Receptors (ALRs) are a family of nuclear and cytosolic foreign-
DNA sensors consisting of an N-terminal PYD and one or two C-terminal DNA-
binding HIN200 domains.  AIM2 is a cytosolic sensor which forms a supramolecular 
structure known as the inflammasome, while IFI16 resides in both the nucleus and 
cytoplasm, where it can associate with ASC and form its own inflammasome, as well 
as lead to activation of the interferon pathway by parallel means.  Persistent 
questions in innate immunology remain of how such sensors respond to foreign 
DNA while remaining silent towards host DNA, as well as their role in activating 
downstream effectors.   
Chapter 2 is devoted to biophysical and biochemical studies of IFI16.  Using 
fluorescence anisotropy, FRET, EMSA, and various mutational studies, it is shown 
that the PYD of IFI16 plays a positive, cooperative role in DNA binding, allowing it to 
oligomerize in a length-dependent manner.  Disruption of the non-DNA-binding PYD 
in turn disrupts DNA binding, demonstrating that oligomerization and DNA binding 
are coupled events.  
In Chapter 3, attention is turned to AIM2.  An autoinhibition model exists in 
the literature to explain AIM2 activation, and this model is tested.  By fluorescence 
anisotropy, FRET, EMSA, electron microscopy, and mutagenesis studies, a simpler 
model which doesn’t invoke autoinhibition is put forth to explain the behavior and 
activation of AIM2.  Results also give clues into how AIM2 may then recruit the next 
member of the downstream pathway, ASC. 
Chapter 4 revisits IFI16 to explore an outstanding question regarding the 
self-vs-nonself problem; namely, do nucleosomes inhibit IFI16 DNA binding and 
oligomerization?  Using time-dependent FRET assays as well as competition 
anisotropy experiments, it is demonstrated that nucleosomes act as effective 
barriers to IFI16 DNA binding and oligomerization.  The length-dependent rates of 
FRET signal also support a model in which IFI16 uses one-dimensional diffusion as 
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Every living organism encodes some means to protect itself against external 
threats.  From E. coli to humans, all are confronted with threats occurring with such 
regularity that such a mechanism is as essential as the means to propagate the 
genomic material.  Some of these are relatively uncomplicated, such as the 
restriction/modification enzyme system in various bacteria [1], while some are 
complex and can even result in changes to the organism’s own genome (CRISPR in 
bacteria, VDJ recombination in white blood cells).  These defenses are referred to, 
collectively, as the immune system.  Many vertebrates, and mammals in particular, 
possess an immune system composed of two branches, the innate and adaptive 
immune system [2].  The adaptive immune system is optimized for long-term, 
specific-target defense: by generating antibodies against poliovirus, one acquires 
immunity to it for many years, but not to other, related, enteroviruses.  These 
antibodies are crafted by a complex process that results in a highly-specific, high 
affinity interaction between the antibody and one part of the antigen [3].  While this 
system is fine-tuned to recognize a unique signal in a sea of various other possible 
signals, a drawback is its speed, or rather, the lack thereof.  The time course of an 
adaptive immune response is on the order of days to weeks [2].  With such a system, 
an organism would quickly succumb to an invader.  Thus, another means must exist 
to prevent us from disintegrating under the onslaught of enemies. 
In contrast to this slow, specialized response to pathogens is the fast, 
generalized innate immune system.  In mammals, this consists of an assortment of 
tissues like the mucosal epithelia, specialized cell types like natural killer cells, and 
protein complexes such as the inflammasome [3].  Various types of cells patrol the 
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body in search of general danger signals, either in the form of pathogen-associated 
molecular patterns (PAMPs) - those signals arising from pathogens such as 
structural components of bacteria - or danger-associated molecular patterns 
(DAMPs), which are signals indicating damage or potential damage to the cell [4] 
[5].  These guardian cells, as well as other cell types, express various molecular 
systems to sense these signals.  Some of these systems reside on the cell surface to 
detect external threats, while others, and the focus of this thesis, reside within the 
cell, either in the nucleus or cytoplasm, to detect internal threats.  These internal 
threats may either be interior damage, such as lysed compartment components, or 
interior invasion, such as by a virus or bacterium.  Upon detection the response can 
be measured, not in days like the adaptive immune response, but in terms of 
minutes and hours. 
One of the hallmark responses of the innate immune system is inflammation, 
a term that encompasses a number of actions on the macroscale and microscale.  At 
the visible level, we see swelling and reddening of the infected tissue; were we to 
turn to the microscope, we would see secretion of signaling molecules, recruitment 
of guardian cells, silencing of pathogen gene expression, and engulfment and 
destruction of the pathogens.  Inflammation doesn’t lead only to the death of the 
invading cells, but also to our own.  Another major outcome is a controlled form of 
cell death, much like apoptosis, referred to as pyroptosis.  This functions to destroy 
cells that have already become infected, as well as to help spread signals to 
neighboring cells to assist them in combating the infection.  The molecular machine 
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responsible for turning on this inflammation-associated cell death pathway is called 
the inflammasome [4] [6]. 
The canonical pathway for assembly of the inflammasome and its 
downstream effects is as follows [4]: upon activation by its respective signal (be it 
DNA, flagellin, urea crystals, or some other PAMP/DAMP), the receptor recruits an 
adaptor molecule.  The adaptor molecule serves as bridge between the sensor and 
the effector, which in the canonical context is procaspase-1.  Procaspase-1 is the 
zymogen form of caspase-1, a cysteine protease that cleaves after aspartate 
residues.  This binding of procaspase-1 to the adaptor leads to activation and 
autocleavage into caspase-1, which goes on to activate the interleukins interleukin-
1β and interleukin-18 by processing the pro-forms.  Interleukins, in turn, are 
secreted, which then turn on the inflammation pathway by activating NF-κB, 
ultimately leading to the release of pro-inflammatory cytokines [4].   
Thus, the inflammasome consists of, usually, three members: the sensor, the 
adaptor, and the effector; sometimes the sensor and adaptor may be united in one 
molecule, or sometimes it may consist of an extra enhancer member; sometimes the 
effector may be a different caspase.  Usually, however, the adaptor and effector 
remain the same, while the sensor may be switched out, allowing for the detection 
of a different signal.  So one may consider “the” inflammasome as, really, a family of 
inflammasomes, which may be distinguished by referring to a specific one as “the 
AIM2 inflammasome” or “the NLRP3 inflammasome,” the qualifier coming from the 
name of the sensor. 
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The nature of the signal is of interest to us for many reasons.  At the basic 
level, we may ask: how do these sensors, which are germ-line encoded and thus, in 
contrast to antibodies, are rather inflexible in terms of signal recognition, recognize 
such a wide variety of different pathogens?  Obviously, differences between the 
pathogen and host should be exploited.  Luckily, there are many characteristics that 
differ between, for instance, a human cell and a bacterial cell; and which, therefore, 
are possible signals to be used as a warning.  The flagellin of a mobile bacterium is a 
prime example; and so it is found to be a signal for the Nod-Like Receptor (NLR) 
family [4].  The presence of a cell wall in Gram-negative bacteria may serve as 
another signal – and indeed it is [4].  However, there are many organisms which 
don’t possess these structures and a different, more general signal must be used, 
and this differentiation begins to break down.  As we draw close to signals that are 
universally shared amongst all organisms – DNA, for instance – we begin to see the 
thin ice our defense system treads in this battle.  Yet even here we are not totally 
lost.  Signature motifs may occur in some organisms which do not occur in ours: 
unmethylated CG dinucleotide (CpG) motifs are one example present in bacteria and 
DNA viruses but rare in mammals, and the Toll-Like Receptor family member TLR9 
is one that recognizes these [7] [8].  AT-rich sequences (a characteristic of some 
pathogens) are recognized by Pol III.  Yet what protection does our defense system 
provide against an enemy which possesses none of these?  
Many times, compartmentalization provides the ability to distinguish self 
from nonself [3].  DNA ought, under normal circumstances in our cells, to be found 
in the nucleus.  A sensor patrolling the cytoplasm would then detect any DNA, which 
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presumably would be there only if foreign DNA had been inserted into the 
cytoplasm or the integrity of the nucleus had been challenged.  If these sensors 
resided solely in the cytoplasm, then perhaps this question of self-versus-nonself 
might not be so interesting – but, in fact, many of them have been reported to 
localize in the nucleus.  What is the mechanism of such a defense?  How does it work 
in one instance (against the invader) and not in another (against the self)? 
Understanding how they work would provide unique insights into this central 
question of innate immunity, but might also provide fodder for how these sensors 
may misbehave, giving rise to such diseases as Sjögren’s syndrome, systemic lupus 
erythematosus, and psoriasis [9] [4].  The focus of the thesis work presented here 
has been on a specific group of these foreign DNA sensors. 
These sensors belong to a family of proteins that has been known by various 
names throughout its history.  It has been called the IFI protein family [10]; p200 
proteins [11]; PYHIN proteins [12], and, most recently, AIM2-Like Receptors [13].  
What this plethora of names reveals is our attempt to encapsulate the essence of the 
family: shall we group them by their homology to a given member (AIM2-Like 
Receptors), or by their shared inducibility (IFI protein family), or perhaps by one of 
their characteristic domains (HIN-200 proteins) – perhaps by both of their 
characteristic domains (PYHIN proteins)?  Each of these appellations provides 
insights into this family of sensors.  In terms of expression, it has been found they 
are induced by type I and type II interferons via consensus IFN-responsive elements 
(ISRE) [14] [15].  The recent naming suggests their similarity to what might be 
considered the quintessential member, but probably is more a reflection of the 
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community’s eagerness to have a unifying naming convention (witness the Toll-Like 
Receptors [TLR], the C-type lectin receptors [CLR], the RIG-I-like receptors [RLR], 
and the NOD-like receptors [NLR]) [16].  Their similarity to each other, however, is 
not forcing a square protein in a circular family, but is very real and probably arose 
from gene duplication events.  Thus, these family members consist of the same 
general domain organization.     
The C-terminal domain consists of the portion that recognizes DNA - the 
HIN200 domain [17] [18].  This acronym is short for hematopoietic, interferon-
inducible nuclear domain of 200 amino acids, of which two of these modifiers are 
not rigidly followed.  While they are expressed in hematopoietic cells, they are not 
exclusively expressed there (AIM2 is found in keratinocytes [9]); and while they are 
found in many proteins localized to the nucleus, they are not exclusively found in 
those (once again, AIM2 being a prime example [9]).  It consists of two subdomains 
that are insoluble when individually expressed [19], the OB-fold 
(oligosaccharide/oligonucleotide binding fold), which is the core of what recognizes 
DNA.  This recognition is mediated almost exclusively by electrostatics: the 
negatively-charged phosphate backbone of DNA interactions with a positively-
charged, basic patch of lysines and arginines in the HIN200 domain [20].  This 
electrostatics-based recognition ensures a nonspecific binding; its ability to 
distinguish DNA from RNA, or single-stranded from double-stranded, is less well-
understood.  It may be that residues inserted into the major groove of DNA grant an 
ability to distinguish DNA from RNA [9], or the width of the binding pocket of the 
protein restricts the ligand to double-stranded DNA.  Reports of isolated HIN200 
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domains binding RNA or single-stranded DNA are in the literature [21], but have not 
been found to hold in the context of the wild-type protein [18]. Little conformational 
change occurs upon binding to DNA, which hints that this domain must not function 
as the sensor in itself; there must be something else to propagate the signal.  This 
leads us to the next domain. 
In keeping with this proliferation of names, the N-terminal domain has gone 
by various names in the course of its career: called the pyrin domain in this work, it 
has also been called the DAPIN domain or the PAAD domain.  The pyrin domain 
(PYD) belongs to a much larger superclass called the death domain (DD) 
superfamily.  This chilling moniker arises from the frequency of these domains in 
proteins involved in cell death pathways.  It’s a deceptively simple piece of protein, 
consisting of six alpha helices bundled together into a little globule, a form 
characteristic of most DDs.  This domain was first characterized as belonging to the 
gene product, called pyrin, responsible for Familial Mediterranean Fever, which is 
characterized by bouts of inflammation as well as amyloidosis.  They are also only 
found at the N-terminus of proteins [22], indicating this positioning may be 
important to its function.  Inevitably in perusing the literature on this domain, one 
encounters the phrase “homotypic interaction” in some form or another [8] [23] 
[11] [9] [24].   This cryptic modifier can be expanded thusly: a protein containing a 
PYD generally can interact with another protein containing a PYD.  There are, of 
course, exceptions and footnotes to this rule, but by and large as a rule of thumb it 
suffices.  This is the basis for its signaling role, and coupled with the HIN200 domain 
it appears we have constructed a minimal sensor. 
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What has emerged in the last few years is an appreciation of the propensity 
of the PYD (and, incidentally, many other DDs) to form long, thin filaments at high 
concentrations, which appear to be essential for their ability to activate the next 
components in the pathway [25].  Many of these filaments shared conserved 
interfaces that allow for templating of the next component of the pathway.  The 
helical filament is believed to provide an advantage of recruiting components of the 
signaling pathway by providing a larger recruitment surface, as well as providing a 
means to generate a distinct on/off mechanism. 
The ALRs work by activating two seemingly mutually exclusive pathways in 
the immune system: either maturation of the interleukins via ASC to caspase, or the 
STING-TBK1-IRF3 axis [26] leading to IFN-β production.  IFN-activating pathways 
are not affected by knocking out ASC [18], demonstrating its independence.  Yet the 
role of a given ALR is not limited to one pathway, as some members have been 
reported to activate different pathways depending on the context [27]. 
The focus of this thesis work has rested on two members of the ALRs, AIM2 
and IFI16, as well as their shared adapter protein ASC.  These will now be 
introduced in a more detailed light for elucidation of the coming pages of 
experiments and findings. 
Interferon-inducible protein 16 (IFI16) [28] has been implicated in diverse 
pathways of the organism, ranging from tumor suppression [19] to inflammation.  
IFI16 is expressed in myeloid cells and fibroblasts as three different isoforms (A, B, 
and C), of which the B form appears to be the most relevant in terms of expression 
level and distribution [29] [11].  These isoforms differ only in the length of linkers 
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between the three domains of the protein.  At the N-terminus, of course, is the PYD.  
This is followed by a long, unstructured linker region containing nuclear-
localization signals, as well as some bona fide and putative post-translational 
modification sites [30].  While IFI16 is found predominantly in the nucleus, it has 
also been isolated in the cytoplasm.  Unusual in the human repertoire, IFI16 
possesses two HIN200 domains, both of which have been shown to bind DNA. 
It wasn’t until 2010 that the important role IFI16 plays in recognizing and 
responding to foreign DNA was truly appreciated [18] .  Until that time, it had been 
characterized offhandedly in conjunction with DNA, such as in the DNA-repair 
complex BASC, as a transcriptional repressor, or as a partner that enhances the 
binding of p53. This binding of foreign DNA induces the recruitment of STING, which 
then activates IRF3 and NF-κB, leading to the expression of IFN-β.  There appears to 
be a strong length-dependency in vivo, as DNA of less than 70bp do not generate a 
strong production of IFN-β [18].  This binding appears to be, as in the case of the 
isolated HIN200 domains, nonspecific, but cooperative [18]. 
IFI16 appears to be special not just due to its extra HIN200 domain, but also 
by the fact that it acts as a foreign DNA sensor in both the cytoplasm [18], where it 
activates the IFN-β pathway, and the nucleus, where it activates the inflammasome 
pathway [27].  This shuttling between the two subcellular compartments is due to 
the NLS located in the linker region between the PYD and the first HIN200 domain, 
which upon acetylation prevents IFI16 from being transported from within the 
cytoplasm to the nucleus [30].  While its cytoplasmic sensing of foreign DNA 
presents no conceptual difficulties, this ability to act as a DNA sensor within the 
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nucleus, where presumably the concentration of host DNA far exceeds that of 
invader DNA, is not well understood.  Evidence of IFI16 as a viral gene silencer and 
its promotion of heterochromatin formation suggesting that chromatinazation plays 
an inhibitory role in this sensing have been put forth [31]. This is an attractive 
hypothesis, as histone-associated DNA may be effectively compartmentalized away 
from IFI16, and linking DNA between histones is between 20-30bp, below the length 
seen to induce robust IFN-β production.  However, no in vitro studies have yet to be 
performed to directly test this hypothesis, as well as to confirm the length-
dependency observed in vivo. 
Absent in Melanoma 2 (AIM2) was first isolated and characterized by Trent 
and colleagues [32] (Ray et al, 1996).  By Northern blot analysis, they found it 
significantly expressed in spleen, small intestine, and peripheral blood leukocytes 
[32].  As with other ALR family members, AIM2’s expression following IFN-β 
induction, as measured via RNA transcripts, was significantly increased in the first 
hour [32].  Of note, AIM2 appears to be a cytosolic DNA sensor, while the other 
members reside in the nucleus [23].  There it interacts with the PYD of ASC to form 
the AIM2 inflammasome [23] [33].  There are two isoforms of AIM2 [9].  Like IFI16, 
AIM2 shows a strong length-dependency, requiring around 80bp to generate a 
robust production of IL-1β [20], but such a response can’t be divined from the 
flavorless, phosphate-backbone-binding cartoon.  So whence this dependency? 
A model of AIM2 activation was put forth by Xiao and colleagues after the 
release of a paper of the crystal structures of the HIN domain bound to DNA [20], as 
well as a following article of the crystal structure of MBP-tagged AIM2 PYD [17].  
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Through molecular docking they were able to show the PYD fits snugly into the 
DNA-binding pocket of the HIN200 domain, the basic patch of the HIN200 
interacting with an acidic patch on PYD.  Through the use of fluorescence anisotropy 
assays of MBP-tagged versions of the full-length protein and the HIN200 domain, 
they showed that the HIN200 domain appeared to bind with better affinity than the 
full length.  These lines of evidence suggested to them the following model.  In the 
resting state, the PYD of AIM2 is folded back and interacting with the DNA-binding 
pocket of the HIN200 domain.  This prevents the PYD from spuriously associating 
with its binding partners.  DNA acts as a competitor for this state, displacing the PYD 
as it binds to the HIN200 domain and activating AIM2 so that it is free to bind to 
ASC.   
Questions with regard to this model arise, however.  As the DNA-binding 
footprint of the HIN200 domain is only 8-bp as shown in the crystal structure, from 
whence does the length-dependent IL-1b secretion response arise?   Would not all 
DNA of length exceeding the footprint allow for activation of AIM2?  While an 
autoinhibition mechanism for ALRs is attractive, as it provides unification with 
other innate immune receptors that operate in such a fashion, such as NLRs and 
RLRs, it may not generalize to other members.  In particular, IFI16 has been shown 
to behave in solution as an extended rod, inconsistent with an autoinhibition model 
[19].  Recently, it has come to light that the AIM2 PYD behaves very similarly to 
other DDs.  At high concentrations, it appears to form filaments.  A paper reporting 
the crystal structure of a PYD variant in which a critical residue for oligomerization 
had been mutated revealed many interesting discrepencies between it and the MBP-
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tagged crystal structure.  Importantly, it showed that an important interface for 
oligomerization was masked in the MBP-tagged version of the PYD, suggesting that 
the tag interferes with the native behavior.  This was borne out by the fact that the 
MBP-tagged version remains soluble and monomeric, while the untagged AIM2-PYD 
readily crashes out of solution and forms large filaments.  The paper also 
demonstrated a number of mutations in the oligomerization interface which could 
disrupt polymerization in vivo.  The role of this polymerization in the autoinhibition 
model has yet to be addressed. 
The last protein that makes up the list explored by this thesis is ASC, referred 
to above as the adaptor protein.  ASC is an acronym for “apoptosis-associated speck-
like protein containing a caspase activating and recruitment domain,” of which this 
meaning will be dissected.  Caspase activating and recruitment domain (CARD) is 
another DD that, in the context of ASC, assists in the conversion of procaspase-1 to 
caspase-1 by binding to the CARD of procaspase-1.  ASC is a small, two-domain 
cytosolic protein, consisting of an N-terminal PYD and the C-terminal CARD.  As ASC 
is an essential component of the inflammasomes, its role in apoptosis, and thus the 
first part of its name, should be apparent.  As the adaptor molecule of the 
inflammasome, ASC is able to interaction with many of the sensors via its PYD.  This 
includes the ALRs associated with the inflammasome, AIM2 and IFI16, as well as the 
other major inflammasome sensors, the NLRs, such as NLRP3.   Finally, upon 
activation, in vivo studies have found ASC to form high molecular weight, speck-like 
punctates in the cell [34].  In vitro, the isolated PYD and CARD of ASC have been 
shown to undergo polymerization, which can be disrupted by select mutations.  
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Interestingly, ASC has been shown to behave in a manner similar to prions, in which 
ASC forms high-molecular weight, detergent-resistant filaments, which in the 
extracellular space can become internalized by nearby cells and convert their 
endogenous, monomeric ASC into filaments [35].  This study provides insight into 
how the inflammation process may be propagated across cells by using components 
of the detection pathway rather than signaling molecules such as interleukins.  
Importantly, it suggests a switch-like mechanism for the pathway, in which a small 
pool of activated molecules may then act as the nucleating point for inactivated 
members.   
Wu and colleagues [33] showed that the presence of AIM2, either as the PYD 
alone or as the full-length in complex with DNA, leads to an enhancement of the 
polymerization of ASC.  This is consistent with another report demonstrating that 
AIM2 enhances the prion-like activities of ASC in vivo [35].  By using gold-labeled 
AIM2-PYD, they were able to show AIM2 localized to one end of the ASC filament, 
indicating that indeed a sub-stoichiometric amount of AIM2 allows for nucleation of 
ASC.  They also provided a high-resolution cryo-electron microscopy map of the 
filament, showing it as a helical assembly with specific symmetry parameters, and 
verified their model by select mutagenesis.  It has been proposed that the AIM2-PYD 
filament will match the symmetry of the ASC filament, thus acting as the template 
for ASC polymerization [36], but the structure and symmetry elements of AIM2 have 
not yet been determined to allow for stronger support of this idea.  If this were to be 
correct, then activated AIM2 may in fact be the nucleator of the prion-like activity 
observed for ASC. 
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Combining the above outline of the players of inflammation, we can revise 
our simple model in a few places of inflammasome activation.  When AIM2 in the 
cytosol or IFI16 in the nucleus detects foreign DNA (how it can distinguish foreign 
from host still remains to be seen) it becomes activated, which in turn leads to 
recruitment of ASC via PYD-PYD interactions.  ASC binding to AIM2 leads to 
polymerization.  This filament then leads to binding of procaspase-1 via CARD-CARD 
interactions.  Due to clustering on the filament of ASC, a local high concentration 
allows self-activation of procaspase-1 by autocleavage, generating mature caspase-
1.  
While the broad details of the pathway appear to be articulated, gaps exist 
which prevent a smooth link between steps.  Two major outstanding questions of 
this pathway, and the focus of this thesis work, are 1) how do ALRs detect foreign 
DNA while at the same time remaining silent to host DNA, and 2) how is this 
detection of signal propagated to the next component of the pathway, namely ASC? 
In regards to the first question, the current model suggests an autoinhibited state 
that should equally respond to both foreign and host DNA given the correct 
conditions [17].  This question is particularly germane to IFI16, which resides in the 
nucleus and for which an autoinhibited state does not appear to exist [19].  With 
regard to the second question, as current research and opinion in the field leans 
towards a two-state, digital model, in which the cell is distinctly either not in the 
inflammation-signaling state, or is distinctly in such a state, the mechanism of ALR 
activation ought to have such an outcome built into it.  The following chapters will 
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IFI16 Cooperatively Assembles Into Filaments on dsDNA: 
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The mammalian innate immune system’s ability to recognize intracellular 
foreign DNA is a widely conserved defense mechanism to detect and respond to 
invading pathogens [1] [2].  Such a universal molecule as a major danger signal for 
detecting pathogens presents dilemmas that must be stringently and efficiently 
overcome, yet only a few factors are known which allows the host innate immune 
system to selectively engage foreign DNA (nonself-DNA) while minimizing 
interactions with the host DNA (self-DNA); such factors include 
compartmentalization of the cell and the size of foreign DNA.  These features, 
however, only raise more questions than provide answers. For example, the 
footprints of intracellular DNA receptors usually fall below 20 bp, and yet a long 
foreign DNA fragment [e.g., poly(dA:dT); ≥1,000 bp] is required to induce a robust 
innate immune response even in a normally DNA-free environment like the 
cytoplasm [1] [2].  On the other hand, foreign DNA-sensing pathways also exist in the 
host nucleus in which DNA receptors must not respond to abundant self-DNA to 
prevent spurious activities [1] [2].  Indeed, one of the major unresolved questions in 
understanding the DNA-sensing pathways of mammals is whether the host 
intracellular DNA receptors have any capacity to distinguish self- from nonself-DNA 
at the molecular level [2]. 
Human IFN inducible protein-16 (IFI16) is an intracellular DNA receptor of 
innate immunity that belongs to the family of absent-in-melanoma-2 (AIM2)-like 
receptors (ALRs) [1] [2] [3] [4].  IFI16 senses DNA from invading pathogens in both 
the nucleus and cytoplasm [e.g., vaccinia virus (VACV) and herpes simplex virus-1 
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(HSV-1)] and plays critical roles in production and maturation of major 
proinflammatory cytokines such as IFN-β and interleukin-1β. Notably, IFI16 is the 
only known host DNA sensor that operates in the nucleus, which is conventionally 
thought to be off limits to DNA receptors due to the abundant self-DNA. In addition 
to its role in defense against foreign DNA, the aberrant activity of IFI16 is also 
associated with several autoimmune disorders, such as systemic lupus 
erythematosus and Sjögren syndrome. IFI16 is involved in the onset and 
progression of these diseases not only by generating abnormally high levels of the 
proinflammatory cytokines but also by being recognized as an autoantigen by the 
host adaptive immune system [4] [5] [6] [7] [8]. 
Despite its implication to host defense and autoimmunity, little is known 
about molecular mechanisms that underlie IFI16. Indeed, there are three major 
unresolved questions regarding its behavior in vivo. First, as observed from several 
other DNA-sensing pathways in mammals, it is not known why long dsDNA (>60 bp) 
is required to induce IFI16 activity [3] [9] [10].  Second, why IFI16 does not bind self-
DNA in the nucleus is not known [11] [12] [13] [14].  Third, it is not known how IFI16 
can selectively assemble into large signaling foci (e.g., inflammasome) with nonself-
DNA [11] [12] [13] [14]. 
Although mechanisms of many proteins can be inferred from their 
structures, the structure of IFI16 does not provide clear answers to the above 
questions. IFI16 is composed of two signature ALR domains, namely one N-terminal 
pyrin domain (PYD) (IFI16PYD) followed by two HIN200 domains (IFI16HinA and 
IFI16HinB). The HIN200 domains nonspecifically bind various ss- and dsDNA 
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fragments on the phosphate backbone via electrostatic interactions with a footprint 
of eight to nine bases, thus confirming that DNA sequence (e.g., the CpG island) is 
not a recognition element [9] [15] [16] [17].  On the other hand, the PYD is a homotypic 
protein-protein interaction domain whose function is thought to be limited to 
recruiting downstream effectors [3] [9] [10]. 
Based on crystallographic and binding studies of related AIM2 and the 
isolated HIN200 domains of IFI16, a general mechanistic model for ALR activation 
was recently proposed [9] [18]. In this model, ALRs assume an autoinhibited 
conformation in which the PYD blocks the DNA-binding surface of the HIN200 
domain. Upon encountering foreign dsDNA, the PYD is displaced and interacts with 
its downstream partners. A long dsDNA fragment is used as a 
pseudooligomerization platform, because the HIN200 domain independently binds 
to either strand of dsDNA with a footprint of about eight bases. The resulting 
ALR⋅DNA complex thus assumes a configuration similar to noninteracting beads on 
a string. Longer DNA fragments simply accommodate more ALRs, allowing the ALR 
pseudooligomers to recruit a greater number of downstream effectors. 
However, these otherwise seminal studies [9] [18] do not explain any of the 
three questions regarding IFI16 behavior. First, it provides no rationale for the DNA 
length-dependent responses observed in vivo. By this model, IFI16 would bind 
equally well to either strand of any dsDNA exceeding its footprint. Thus, any dsDNA 
long enough to promote minimal IFI16 oligomer for downstream effector 
interaction (e.g., dimer for procaspase-1 activation; 10 bp) would produce similar 
responses at the same mass concentration. Second, this model provides no insight 
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into how IFI16 suppresses its interaction with self-DNA in the nucleus. For instance, 
AIM2 has only one HIN200 domain and is exclusively localized in the cytoplasm [19]. 
By contrast, IFI16 has two HIN200 domains that can bind either ss- or dsDNA and 
assumes an uninhibited open conformation, and its footprint falls within the range 
of the exposed dsDNA linker between host nucleosomes (10–20 bp) or transcription 
bubbles (∼17 bases) [12] [20] [21] [22]. Indeed, the proposed autoinhibitory 
mechanism would be effective only in an intrinsically DNA-free environment like the 
cytoplasm but not in the nucleus, where abundant self-DNA would easily displace 
IFI16PYD from either HIN200 domain. Finally, it does not explain how IFI16 can 
selectively colocalize with foreign DNA and assemble into large signaling foci. The 
total amount of DNA under normal or infectious conditions easily exceeds that of 
IFI16. Thus, by this model, IFI16 would be scattered on foreign and self-DNA instead 
of selectively forming signaling foci on nonself-DNA (e.g., in principle, one genome of 
HSV-1 contains more than 30,000 binding sites).  
Here, by using quantitative assays and electron microscopy, I found that 
cooperatively assembling into filamentous oligomers on dsDNA may underlie the 
observed behaviors of IFI16 in vivo. IFI16 binds dsDNA in a nonlinear length-
dependent manner and forms oligomers that are clearly different from entities 
resembling beads on a string. The isolated HIN200 domains of IFI16 do not 
oligomerize and thus engage dsDNA with weak affinity. However, in contrast to the 
PYD of AIM2, IFI16PYD plays an unexpected positive role in DNA binding as it drives 
the filament assembly. The surface residues that are important for dsDNA binding in 
IFI16PYD are highly conserved, indicating that other ALRs use the same strategy. 
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These results reveal that IFI16 is poised to rapidly engage even a single piece of long 
nonself-DNA with a switch-like mechanism (e.g., HSV-1 genome), while not 
responding to much higher concentrations of short self-DNA exposed under normal 






















Assembling signal⋅receptor complexes is a critical regulatory step in virtually 
all known signaling pathways, because this first step commits the rest of the cascade 
in a switch-like mechanism [23] [24]. I reasoned that it is unlikely that regulation of 
IFI16 pathways is only accomplished by yet unknown downstream events. The 
currently prevailing mechanistic model for IFI16 was established by studying its 
isolated HIN200 domains, which nonspecifically bind any DNA exceeding their 
footprints equally well [3] [9] [15]. In contrast, studying the full-length protein might 
better address the DNA-sensing strategy of IFI16. Thus, for this work, I first 
successfully generated full-length and the functional domains of IFI16 without 
solubility tags in high purity (Figure 2.1A–C) and also developed various in vitro 














Figure 2.1: Purification of IFI16 constructs used in the study.  (A) Sample 
images from size-exclusion chromatography of IFI16 constructs used.   IFI16PYD was 
purified using Superdex-75 16/600, while all the other constructs were purified 
using Superdex-200 16/600.  All elution volumes correspond to monomers 
according to the manufaturer’s guidelines (GE Healthcare).  (B) A Sample UV-visible 
absorbance profile of full-length IFI16.  (C) An SDS-PAGE image of IFI16 constructs 





2.2.1 IFI16 Binds dsDNA in a Length-Dependent, Cooperative Manner 
The DNA length-dependent responses of IFI16 observed in vivo may arise 
directly from differences in binding affinity for different-length DNA ligands but not 
from an as yet unidentified regulatory mechanism mediated by downstream 
effectors. To test this, I developed fluorescence-anisotropy (FA) binding assays 
using various fluorescein-amidite (FAM)-labeled DNA fragments. Monitoring FA of 
FAM-dsVACV72 (a 72-bp fragment derived from VACV [3]; Table 2.1) with 
increasing concentrations of IFI16 resulted in a sigmoidal binding isotherm which a 
Hill equation could best fit [an apparent binding constant (KDapp) of 65 ± 19 nM and 
a Hill coefficient of 1.9 ± 0.2; Figure 2.2A]. This result indicated that full-length 
IFI16, unlike its isolated HIN200 domains [3] [9] [15], binds dsDNA in a cooperative 
manner.  I then tested the binding of shorter dsDNA variants of VACV and HSV 
fragments that were used in the previous in vivo study [3]. In contrast to predictions 
from the previously proposed model [9], I found that the binding affinity decreased 
with decreasing length of the dsDNA fragments independent of sequence (Figure 
2.2B, Table 2.1, and Table 2.2). Importantly, the calculated Hill coefficients also 
decreased with shorter dsDNA (e.g., Figure 2.2B,C), suggesting that an absence of 
cooperativity results in weaker affinity (see also Table 2.2).  
A possible underlying mechanism for the cooperative length-dependent 
binding is that IFI16 assembles into a distinct oligomer on dsDNA, because such a 
protein cluster would result in a more stable complex than the previously proposed 
noninteracting beads on a string [9]. To test this idea, I first determined the 
stoichiometry between IFI16 and dsDNA ligands by performing FA experiments 
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using FAM-dsDNA concentrations at least six times higher than their respective 
KDapp values (e.g., Figure 2.2D). The plot of dsDNA length vs. the number of bound 
molecules revealed that about 15 bp are required to accommodate one full-length 
IFI16 (Figure 2.2E), which agrees with a previous report suggesting that one 
HIN200 domain takes up about eight to nine bases. Notably, because no significant 
binding was observed from FAM-dsHSV15, these results also suggest that 
oligomeric IFI16 is required for tight binding (see also below). To confirm the 
length-dependent binding, I normalized the KDapp of each fragment to the number of 
available binding sites on each dsDNA fragment (e.g., four for dsHSV60). Plotting 
normalized KDapp vs. dsDNA-length revealed that the binding affinity of IFI16 still 
increases with increasing DNA length (Figure 2.2F), supporting the idea that IFI16 
cooperatively oligomerizes on dsDNA in a length-dependent manner. Importantly, 
these results correlate with the previously reported dsDNA length-dependent 
responses in vivo [3] and thus suggest that cooperatively assembling stable 











Figure 2.2:  IFI16 cooperatively binds dsDNA in a length dependent manner.  
(A) Binding of full-length IFI16 to FAM-dsVACV72 (2.5 nM) was monitored by 
changes in FA.  The fraction bound was calculated as (A – A0)/(Amax – A0), where A0 
is the anisotropy of the free DNA and Amax is the anisotropy of the saturating 
protein.  The lines are fits to a Hill form of binding equation (number of independent 
experiments n = 3).  (B) Binding of IFI16 to each FAM-dsDNA was determined by FA.  
The lines are fits to a Hill equation: fraction bound = 1/(1 + KDapp/[IFI16])Hill 
Coefficient).  The determined values are listed in Table 2.2.  (C) The data for dsHSV33 
and dsHSV24 from (B) were replotted to demonstrate their noncooperative binding 
profiles. (D) The stoichiometry between IFI16 and dsVACV72 was determined using 
the concentration of FAM-dsVACV72 sixfold higher than its determined KDapp (Table 
2.2).  The lines are fits to a quadratic binding formula.  Shown is representative of n 
= 3.  (E) Stoichiometry of IFI16 to dsDNA was determined by plotting the number of 
bound IFI16 molecules vs. dsDNA length (dsVACV72, dsHSV60, dsVACV52, and 
dsHSV33) (n = 3).  (F) A plot of binding-site normalized KDapp vs. dsDNA length for 
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dsDNAxxx xxx-bp PCR fragments of dsDNA 
 





DNA KDapp, nM Normalized KDapp, nM Hill Coefficient 
dsVACV72 65 ± 19 325 1.9 ± 0.2 
dsHSV60 128 ± 31 512 1.5 ± 0.1 
dsVACV52 172 ± 32 596 1.3 ± 0.1 
dsHSV39 245 ± 21 637 1.2 ± 0.1 
dsHSV33 461 ± 53 1,014 1.1 ± 0.1 
dsHSV24 864 ± 98 1,382 1.1 ± 0.1 
dsHSV15 NB ND ND 
 
Table 2.2: Binding of IFI16 against various dsDNA as measured by 
fluorescence anisotropy.  The apparent binding affinities (KDapp values) and Hill 
coefficients are mean values of at least three independent FA experiments.  Each 
FAM-labeled DNA was used at least 20-fold lower than the determined KDapp (n = 3; 






2.2.2 IFI16 Oligomers Are Distinct Protein Clusters 
In contrast to the previous model in which IFI16⋅dsDNA complexes resemble 
noninteracting beads on a string [9], these binding experiments suggested that IFI16 
assembles into distinct oligomeric clusters on dsDNA. These two models can be 
distinguished by monitoring formation of FAM-dsDNA⋅IFI16 complexes in the 
presence of increasing amounts of unlabeled DNA using native gel electrophoretic 
mobility-shift assays (EMSAs): the clustering mechanism would show a concerted 
transition without resulting in significant intermediates, whereas the noninteracting 
mechanism would clearly display intermediate species [25] [26]. Despite extensive 
efforts to optimize conditions, IFI16⋅dsVACV72/HSV60 complexes did not fully 
enter into the EMSA gel matrix. This was likely caused by the unusually high pI of 
IFI16 (pI: 9.3), as similar results were observed for AIM2 (pI: 9.8) and other DNA-
binding proteins with high pI values [10] [27]; thus analyses of EMSA is limited to 
qualitative purposes only. Nevertheless, judging by the disappearance of free FAM-
dsDNA and by the formation of only a few transient intermediates, these results are 
consistent with the FA assays in which IFI16 binds dsDNA cooperatively and 
eventually form an oligomer on each dsDNA in a length-dependent manner (Figure 
2.3A). I then performed a competition EMSA in which increasing concentrations of 
unlabeled dsAG60 were added to FAM-dsVACV72⋅IFI16 (Figure 2.3B). As predicted 
from the clustering model, IFI16 bound dsVACV72 in a concerted manner without 
forming distinct intermediates. Importantly, the lack of intermediates in this assay 
indicates that IFI16 preferentially clusters even if there are nonadjacent excess 




Figure 2.3: IFI16 cooperatively clusters on dsDNA.  (A) EMSAs of various dsDNA 
(5 nM) against increasing concentrations of IFI16 (0, 1.5, 3, 6, 12, 24, 48, and 96 
nM).  (B)and EMSA in which increasing concentrations of dsAG60 (1.5, 3, 6, 12, 23, 











2.2.3 IFI16 Oligomerizes on dsDNA in a Switch-Like Manner 
To quantitatively determine the oligomerization efficiency of IFI16 in the 
presence of excess DNA, I developed a Förster resonance energy transfer (FRET) 
assay by labeling one batch of IFI16 with a FRET donor and another with an 
acceptor. Importantly, because I am adding increasing amounts of excess DNA to a 
fixed concentration of IFI16, FRET signals are expected to arise only if IFI16 
preferentially binds next to one another even in the presence of excess nonadjacent 
binding sites. Indeed, adding increasing amounts of unlabeled dsVACV72 to an 
equimolar (20nM each) mixture of FRET-labeled IFI16 produced changes of the 
emission ratios between the donor (decrease) and acceptor (increase) that could fit 
to a Hill equation (I denote the midpoints of these curves as KFapp values, apparent 
oligomerization constants; Figure 2.4A,B,C and Table 2.3). No significant FRET 
signals were observed from ssDNA (e.g., ssVACV72) or dsDNA shorter than 60 bp 
(e.g., Figure 2.4A, inset). The amplitudes of the FRET ratios from dsDNA fragments 
longer than 72 bp were greater but otherwise did not differ significantly from one 
another, indicating that all labeled IFI16 molecules used in the assay were bound to 
these fragments to form similarly sized oligomers (Figure 2.4B). After determining 
the KFapp value for each dsDNA fragment, I plotted relative binding efficiency 
(normalized to the KFapp of dsDNA2000) vs. dsDNA length to analyze how the 
oligomerization (binding) efficiency of IFI16 changes with respect to the length of 
dsDNA. This plot shows a cooperative relationship best fit with a Hill coefficient of 
5.2 ± 0.6 and the optimal oligomerization efficiency (infliction point) around 150 bp 
(indicated by the arrow in Figure 2.4C).  The Hill coefficient of about 5 in this plot 
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indicates that a small fixed amount of IFI16 can dramatically amplify its 
oligomerization efficiency with increasing length of dsDNA in a switch-like manner. 
Moreover, the infliction point at 150 bp suggests that about ten IFI16 molecules 






















Figure 2.4: IFI16 oligomerizes on dsDNA with a switch-like mechanism.  (A) A 
sample fluorescence emission spectra of an equimolar mixture of FRET donor 
(Dylight 550)- and acceptor (Dylight 650)-labeled IFI16 with increasing 
concentrations of dsVACV72 (0, 1.5, 3, 6, 12 24, 48 µg/mL; excitation at 522 nm). 
A.U., arbitrary units; RFU, relative fluorescence units. Inset: the emission spectra of 
FRET-labeled IFI16 with increasing concentrations of dsHSV24 (0, 10, 20, 50, 100 
µg/mL). (B) A sample plot of changes in the ratio between the FRET donor emission 
(λmax: 578 nm) and the acceptor emission (λmax: 678 nm) at each indicated dsDNA 
concentration. The apparent oligomerization constants (KFapp) were obtained by 
fitting the data to a Hill equation (Table 2.2), and shown is a representative of n = 3. 
(C) A plot of binding efficiency vs. the length of dsDNA for IFI16. The data were fit to 
a Hill equation. The efficiency was determined by normalizing the mean KFapp of 





DNA KFapp, nM Normalized KFapp, nM Hill Coefficient 
dsHSV60 165 ± 25 660 1.3 ± 0.2 
dsVACV72 46 ± 16 218 1.8 ± 0.1 
dsDNA120 14 ± 6 113 1.6 ± 0.2 
dsDNA200 7.8 ± 1.7 104 1.8 ± 0.3 
dsDNA300 6.2 ± 0.5 124 2.3 ± 0.5 
dsDNA600 2.3 ± 0.4 91 1.8 ± 0.1 
dsDNA2000 0.8 ± 0.1 102 1.6 ± 0.2 
 


















2.2.4 HIN200 Domains Bind dsDNA Noncooperatively and Result in Weaker 
Affinity 
To identify the functional domain of IFI16 that drives filament formation, I 
generated the individual and tandem HIN200 domains of IFI16 (IFI16HinA, IFI16HinB, 
and IFI16HinAB; Figure 2.1) and assayed their binding to FAM-dsVACV72. 
Surprisingly, I did not observe significant dsDNA binding from these IFI16 variants 
(e.g., Figure 2.5A, Upper). It was previously reported that dsDNA-binding affinity of 
IFI16HinB was significantly influenced by buffer salt concentrations [9]. Indeed, I 
found that the near-physiological salt concentrations (160 mM KCl) in the reaction 
buffer interfered with binding (Figure 2.5A, Lower). Unlike full-length, the 
disappearance of free FAM-dsVACV72 and dsHSV60 was apparently noncooperative 
even under 60 mM KCl, suggesting that the DNA-bound complexes formed by the 
tandem HIN200 domains of IFI16 must resemble noninteracting beads on a string 
(Figure 2.5A,B). To detect binding of the individual HIN200 domains, I decreased 
the KCl concentration even further to 20 mM. Here, I found that all IFI16 variants 
but IFI16PYD bound dsDNA in decreasing order of affinity: full-length, IF16HinAB, 
IFI16HinA, IFI16HinB. Importantly, as expected from the EMSA, the fits to the isolated 
HIN200 domains binding to dsVACV72 were noncooperative (Hill coefficients, ∼1, 
Figure 2.5C). These results suggest the HIN200 domains of IFI16, individually or in 
tandem, do not efficiently bind dsDNA because they fail to cooperatively 
oligomerize.  
Several additional experiments performed at 60 mM KCl confirmed that the 
tandem HIN200 domains of IFI16 do not oligomerize. First, in FA binding assays, I 
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found that unlike full-length, IFI16HinAB bound all FAM-dsDNA fragments 
noncooperatively and without apparent length-dependency (Figure 2.5D,E vs. 
Figure 2.2). Second, in an EMSA competition experiment similar to Figure 2.3B, 
IFI16HinAB clearly displayed intermediates (Figure 2.5F). Third, no significant FRET 
signals were observed from donor- and acceptor-labeled IFI16HinAB using increasing 
concentrations of dsVACV72 (Figure 2.5G vs. Figure 2.4A). These results 
consistently support the idea that the HIN200 domains of IFI16 do not cooperatively 


















Figure 2.5: The HIN200 domains of IFI16 do not oligomerize on dsDNA. (A) An 
EMSA of IFI16HinAB to FAM-dsVACV72 (2 nM) at 160 mM KCl (Upper) and 60 mM KCl 
(Lower) (IFI16HinAB: 0, 1.5, 3, 6, 12, 24, 48, and 96 nM). (B) An EMSA of full-length 
IFI16 (50, 100, 200, 400 nM) and IFI16HinAB (100, 200, 400, 800 nM) to FAM-
dsHSV60 (20 nM). (C) Binding of IFI16 variants to FAM-dsVACV72 were determined 
by FA at 20 mM KCl. The determined values are listed in Table 2.3. The data for full-
length IFI16 were fit with a quadratic form of binding equation, and the others were 
fit with a Hill equation. Shown is a representative of n = 4. (D) Binding of IFI16HinAB 
toward indicated FAM-dsDNA fragments (5 nM each) was determined by FA at 60 
mM KCl. The lines are fits to a Hill equation. Shown is a representative of four 
independent experiments. (E) Binding-site normalized KDapp values of IFI16HinAB 
from D (n = 4; ±SD). (F) An EMSA in which increasing concentrations of dsAG60 
(190, 95, 45, 23, 12, 6, 3, and 1,5 µg/mL) were added to IFI16HinAB⋅FAM-dsVACV72 
(250 nM and 0.2 µg/mL, respectively) using 60 mM KCl.  (G) The lack of FRET 
signals for donor- and acceptor-labeled IFI16HinAB (100 nM each) with increasing 








2.2.5 The PYD of IFI16 is Necessary for Cooperative DNA Binding 
Conventionally, the role of PYDs in ALRs is thought to be limited to recruiting 
downstream effectors [1] [19] [28]. However, several independent experiments I have 
performed thus far suggested that IFI16PYD is important for oligomerization on 
dsDNA. To test this possibility, I first confirmed that IFI16PYD is a monomer and does 
not directly bind dsDNA (Figure 2.6A; see also Figure 2.1A). Next, I constructed 
IFI16 variants consisting of either IFI16PYD and IFI16HinA (IFI16∆B; residues 1–393) 
or IFI16PYD and IFI16HinB (IFI16∆A; residues 1–191 plus 459–729) (see also Figure 
2.1). At 160 mM KCl, I found that IFI16∆B efficiently binds dsVACV72 and IFI16∆A 
binds dsVACV72 more weakly than IFI16∆B, likely reflecting the weaker binding 
affinity of the IFI16HinB in my hands compared with the previous report [3] (Figure 
2.6A,B and Table 2.4). Importantly, unlike the IFI16 constructs without the PYD, 
the binding profiles were positively cooperative (Figure 2.6B and Table 2.4).  
PYDs are homotypic protein-protein interaction domains in which multiple 
binding surfaces are used in their interactions [29]. For example, helices one and 
four dock on helices two and three to create a high-affinity oligomeric interaction 
[30] (see also Figure 2.6D). To identify surface residues in IFI16PYD important for the 
cooperative filament formation, I generated a set of mutations on the conserved 
surface residues using a homology model of IFI16PYD based on the PYD of myeloid 
cell nuclear differentiation antigen (MNDA) (Protein Data Bank ID code 2DBG; 88% 
sequence similarity; Figure 2.6C,D). I found that mutating these surface side-chains 
on IFI16PYD resulted in up to 25-fold increase in KDapp values for FAM-dsVACV72 
compared with wild-type (Figure 2.6E and Table 2.4). In addition, the binding 
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profiles of IFI16mut2 and IFI16mut3 were essentially noncooperative (Hill coefficients: 
∼1 for both; Figure 2.6E), indicating that the cooperative dsDNA-binding 
mechanism requires intact IFI16PYD. Also supporting the FA results, IFI16mut3 bound 
FAM-dsVACV72 significantly weakly compared with wild-type with an altered 
migration pattern in an EMSA (Figure 2.6F, Upper). Moreover, unlike wild-type, 
IFI16mut3 showed intermediates in a competition ESMA (Figure 2.6F, Lower). 
Finally, no FRET signal was observed between an equal mixture of donor-labeled 
IFI16HinAB and acceptor-labeled full-length IFI16 with increasing dsVACV72 at 60 
mM KCl (Figure 2.6G). The lack of FRET signal in this experiment suggests that 
IFI16PYD interacts with one another instead of interacting with adjacent HIN200 
domains on the dsDNA scaffold. Taken together, I concluded that the conditional 
proximity induced upon encountering dsDNA by the HIN200 domains triggers 













Figure 2.6: IFI16PYD plays a positive role in cooperative oligomerization. (A) 
EMSAs of IFI16PYD (Top), IFI16∆A (Middle), and IFI16∆B (Bottom) to FAM-dsVACV72 
at 160 mM KCl (0, 1.5, 3, 6, 12, 24, 48, and 96 nM; for IFI16PYD: 15, 30, 62, 125, 250, 
500, and 1,000 nM). (B) Binding of IFI16HinAB, IFI16∆A, and IFI16∆B to FAM-
dsVACV72 was determined by FA at 160 mM KCl. The data were fit with a Hill 
equation (Table 2.4). Shown is a representative of n = 3. (C) A sequence alignment of 
the PYDs of various ALRs. The mutated residues are highlighted, and the alignment 
was generated using ClustalOmega (www.clustal.org). P204 is a mouse homolog of 
IFI16, and all of the other proteins are human ALRs. (D) A homology model of 
IFI16PYD was generated using the PYD of MNDA as a template and the SWISS-MODEL 
server. Mutated side chains are shown with a stick representation; the figure was 
generated using PyMOL (DeLano Scientific). (E) Binding of each mutant IFI16 to 
FAM-dsVACV72 was determined by FA at 160 mM KCl. The wild-type data from 
Figure 2A are shown for comparison. The determined values are listed in Table 2.4, 
and shown is a representative of n = 3. (F, Upper) an EMSA-binding assay of 
IFI16mut3 (0, 3, 6, 12, 24, 48, 96, 192, 384, 768 nM) to FAM-dsVACV72 (0.4 µg/mL). 
(F, Lower) An EMSA in which increasing concentrations of dsAG60 (0, 1.5, 3, 6, 12, 
23, 45, and 190 µg/mL) were added to IFI16mut3⋅FAM-dsVACV72 (768 nM and 0.2 
µg/mL, respectively). (G) The lack of FRET signals from an equal mixture of donor-
labeled IFI16HinAB and acceptor-labeled full-length IFI16 (50 nM each) with 





IFI16 Construct KDapp, nM Hill Coefficient 
20mM KCl 
Full-Length 0.5* ND 
IFI16HinA-B 12 ± 2 1.0 ± 0.1 
IFI16HinA 51 ± 8 1.0 ± 0.1 
IFI16HinB 768 ± 87 1.0 ± 0.1 
IFI16PYD NB ND 
160mM KCl 
Full-Length 65 ± 19 1.9 ± 0.2 
IFI16ΔA 458 ± 83 2.2 ± 0.4 
IFI16ΔB 197 ± 45 1.7 ± 0.2 
IFI16D50A 77 ± 15 1.8 ± 0.2 
IFI16mut1 195 ± 24 1.5 ± 0.1 
IFI16mut2 708 ± 87 0.8 ± 0.2 
IFI16mut3 1,580 ± 220 1.0 ± 0.1 
 































2.3.1 What Could Be the Molecular Basis for DNA Length-Dependent 
Responses? 
Conventionally, it was thought that IFI16 and its related ALRs prefer long 
dsDNA as it can accommodate a greater number of ALRs, which would be required 
to promote multimeric protein⋅protein interactions with their downstream partners 
[3] [9] [18]. However, an important point to consider here is that if IFI16 binds dsDNA 
resembling beads on a string as previously thought, longer DNA fragments can be as 
counterproductive for multimeric interactions as short fragments. For example, 
even one femtogram of transfected 100-bp DNA fragments (≥9,000 copy number) 
provide more than 100,000 equally plausible nonadjacent binding sites for the 
HIN200 domains of IFI16. Furthermore, in principle, one HSV-1 genome contains 
more than 30,000 binding sites. Thus, because IFI16 lacks any DNA sequence 
specificity, without an intrinsic clustering mechanism mediated by protein⋅protein 
interactions, IFI16 would be randomly scattered on any self- or nonself-DNA 
(Figure 2.7A) instead of selectively forming signaling foci on foreign DNA as 
observed in vivo [11] [12] [13] [14]. These results suggest that the PYD-driven filament 
formation by IFI16 can provide an effective mechanism that allows multiple IFI16 
(or its related ALRs) to bind adjacent to one another to form signaling foci even in 





Figure 2.7: Two models for IFI16. (A) The conventional model lacks any 
regulatory mechanism that can account for the observed behavior of IFI16 in vivo. 




















2.3.2 What Is a Potential Regulatory Mechanism of IFI16 in the Nucleus? 
A striking behavior of IFI16 is that even though it is localized in the nucleus, 
it is randomly diffused without forming distinct foci with self-DNA [11] [12] [13] [14]. 
In fact, one of the longest-standing questions regarding IFI16 is how it does not 
engage self-DNA in the nucleus [11] [12] [13] [14] [31] [32]. I show here that the HIN200 
domains of IFI16 possess negligible DNA-binding capacities under physiologically 
relevant salt concentrations [i.e., KD >> 10 µM for the HIN domains in the ∼200 mM 
effective salt concentrations of the host cell nucleus [33]]. Importantly, the 
interaction between the HIN200 domains and dsDNA are exclusively mediated by 
the phosphate backbone [i.e., nonspecific electrostatics [9]]. Although useful in 
engaging a wide variety of foreign DNA, this intrinsically weak intermolecular force 
does not generate enough binding energy beyond formation of an encounter 
complex [34]. Thus, despite exceeding the footprint of the HIN200 domains, the 
length of the exposed linker-dsDNA between nucleosomes [10–20 bp [21]] or even 
that of the transcription bubble [∼17 bases [22]] is too short to promote robust 
filament assembly of IFI16. Additionally, I envision that requiring oligomerization to 
achieve tight binding also plays a negative role in competing against 
replication/transcription machinery. Thus, these data suggest that the weak binding 
capacity of its HIN200 domains coupled with filament formation could sufficiently 




2.3.3 How Can IFI16 Selectively Engage Foreign DNA and Assemble into Large 
Signaling Foci? 
IFI16 is known to selectively colocalize with viral genomic DNA to form 
signaling foci within the nucleus (e.g., HSV-1, KSHV) [11] [12] [13] [14]. Although the 
total amount of viral DNA would never exceed that of self-DNA, there are two 
features of foreign DNA that are much more conducive to filament formation by 
IFI16. First, the entire naked DNA genome is exposed immediately after the invasion 
[35] [36] [37]. Second, although the viral genome packages into chromatin with the 
host histones, it is less dense and much more loosely packed than the nuclear self-
DNA [35] [36] [37]. Importantly, I find that the relative binding affinity of IFI16 to 
various dsDNA fragments changes cooperatively not only with increasing IFI16 
concentrations (Figure 2.2) but also with increasing number of binding sites 
(dsDNA lengths; Figure 2.4). These highly cooperative relationships suggest that 
IFI16 is capable of amplifying its clustering behavior in a switch-like manner. For 
example, the Hill coefficient of about 5 from Figure 2.4C suggests that even the low 
basal amount of IFI16 [38] prefers by more than 2,000-fold to oligomerize on a 150-
bp fragment rather than simply binding to a 15-bp fragment. Additionally, by these 
cooperative mechanisms, the binding efficiency diminishes in the same manner it is 
amplified; thus, these results suggest that IFI16 can clearly define an “on” or “off” 
state with respect to its concentration and the length of dsDNA. Collectively, the 
filament formation by IFI16 provides a compelling mechanism by which it could 
selectively engage foreign DNA while minimizing its interaction with self-DNA.  
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2.3.4 The Role of PYD. 
In contrast to the autoinhibitory role of the PYD of AIM2 [9] [18], I find that 
IFI16PYD plays an unexpected positive role in dsDNA binding. Several surface 
residues in IFI16PYD that mediate the cooperative dsDNA binding of IFI16 are highly 
conserved (Figure 2.6C), thus suggesting that other related ALRs use a common 
oligomerization mechanism. Interestingly, I find that the PYD-driven filament 
assembly could provide two important tactical advantages that might not be 
attainable by the previously proposed noninteracting model [9]. First, it allows 
formation of an ordered array of IFI16PYD oligomers on foreign DNA even with the 
low basal concentration of IFI16 in vivo [38]. The IFI16PYD cluster would then be 
instrumental for subsequent steps in IFI16 signaling pathways, because assembling 
PYD/CARD oligomers by receptor molecules is required for recruiting downstream 
partners [23] [24] [39]. Second, the PYD-driven filament assembly ensures formation 
of a high-affinity IFI16⋅foreign DNA complex for signaling, which would also directly 
interfere with replication of pathogens. Indeed, IFI16 can directly suppress 
replication of human cytomegalovirus (HCMV) without downstream activation of 
IFN-β [40]. The authors of this report [40] also showed that this intrinsic antiviral 
activity of IFI16 required its PYD, supporting the positive role in engaging foreign 
DNA in vivo. Finally, further consistent with the positive role of IFI16PYD, very recent 
results published while this paper was under review showed that IFI16 
oligomerizes on HCMV genome via its PYD in human fibroblasts and that a viral 
protein (pUL83) sequesters IFI16PYD to evade the host immune response [41]. Future 
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studies could reveal how PYDs regulate the function of IFI16 and its related ALRs in 
more detail.  
2.3.5 Filament Formation as a Broad Host Defense Strategy. 
Conventionally, assembling filaments on foreign nucleic acids has been 
considered as a defense strategy reserved for sensing intracellular RNA [28] [42]. For 
example, a principal mechanism by which melanoma differentiation associated 
protein (MDA)5 distinguishes self- from nonself-RNA is via cooperatively 
assembling into filaments along the length of long dsRNA with its two CARDs 
forming clusters tracing the center of filaments in a helical trajectory [25] [26] [42] [43] 
[44] [45]. IFI16 and MDA5 are unrelated proteins, and, not surprisingly, mechanisms 
allowing these proteins to assemble into filaments are significantly different. For 
example, the RecA-like RNA-sensing domain of MDA5 wraps around dsRNA and 
promotes filament formation in a head-to-tail manner; the CARD clusters are not 
required for filament assembly. In contrast, the DNA-binding domains of IFI16 do 
not directly promote filament formation, and yet its PYD is necessary to drive this 
process. Interestingly, the data suggest that an optimal binding unit consists of 
approximately ten IFI16 protomers (Figure 2.4C). It is tempting to speculate that 
the filament assembly is then accomplished by propagating these decameric units 
along the length of dsDNA. Another difference between IFI16 and MDA5 is that the 
helicase domain regulates the lifetime of MDA5 filaments via ATP hydrolysis, 
although it is not clear what triggers the disassembly of IFI16 filaments. Further 
structural and kinetic studies could reveal the architecture and dynamics of IFI16 
filaments in more detail. Overall, regardless of these mechanistic differences, the 
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results suggest that assembling filaments of intracellular dsDNA/dsRNA receptors is 
not only an effective mechanism but also a broadly conserved host defense strategy 























2.4.1 Protein Expression and Purification. 
Human IFI16 full-length (residues 1–729), IFI16PYD (residues 1–93), IFI16HinA 
(residues 192–393), IFI16HinB (residues 518–729), IFI16HinAB (residues 192–729), 
IFI16∆A (residues 1–191 + 459–729), and IFI16∆B (residues 1–393) were cloned into 
a pET21b vector (Novagen) using standard PCR methods. The identity of each IFI16 
construct and mutant was confirmed by DNA sequencing. IFI16 constructs were 
expressed using T7 express cells (NEB). The cells were grown until OD600: 0.5 at 37 
°C and protein expression was induced by 0.2 mM isopropyl β-d-1-
thiogalactopyranoside overnight at 18 °C. Each protein construct was purified using 
Ni2+-nitrilotriacetic acid (NTA) affinity chromatography (Qiagen), followed by cation 
exchange chromatography using a Resource S column (GE Healthcare) with a NaCl 
gradient (50 mM to 1 M) and Superdex-200 or Superdex-75 size-exclusion 
chromatography (GE Healthcare). Micrococcal nuclease (NEB; 100 units per 1 L of 
cells) was added during cell lysis to eliminate bacterial DNA contamination. All 
proteins were eluted as monomers in size-exclusion chromatography (Figure 2.1A), 
and UV-visible spectroscopy confirmed that they were free from nucleic acid 
contamination (Figure 2.1B). Each protein was greater than 95% pure (Figure 
2.1C) and concentrated and stored at −80 °C in 20 mM Hepes⋅NaOH at pH 7.4, 200 
mM NaCl, 1 mM EDTA, 5 mM DTT, and 10% (vol/vol) glycerol.  
2.4.2 DNA. 
Each FAM-labeled and unlabeled DNA fragment shorter than 120 bp was 
commercially purchased from Integrated DNA Technologies (IDT; Table 2.1). 
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Duplex formation was achieved by mixing the sense and the complementary strands 
in 1:1 molar ratio in buffer A (see below) and heating in 95 °C for 10 min. The 
duplex samples were subsequently cooled to room temperature (25 ± 2 °C) on the 
bench top. The longer dsDNA fragments were generated by PCR using a plasmid. 
Under the reaction conditions, all duplex DNAs are at least 15 °C below their 
predicted melting temperatures (SciTools; IDT).  
2.4.3 Biochemical Assays. 
Unless noted otherwise, all assays were performed at room temperature (25 
± 2 °C) with 40 mM Hepes⋅NaOH at pH 7.4, 160 mM KCl, 1 mM EDTA, 2 mM DTT, 
10% glycerol, and 0.1% Triton-X100 (referred to as buffer A). The FA of FAM-
labeled DNA (at least 15- to 20-fold lower concentrations than the KDapp for each 
experiment) was monitored with increasing concentrations of IFI16 variants by 
using a Tecan M1000 plate reader (excitation at 470 nm and emission at 528 nm) 
and 384-well nonbinding plates (Corning), and FA values were determined by 
iControl data analysis software (Tecan). The concentration of each FAM-dsDNA was 
kept at least 20-fold less than its respective KDapp in each binding assay to prevent 
any length bias (typically 2.5–5 nM per assay). For EMSA, each DNA was incubated 
with indicated concentrations of IF16 variants for 10 min and the bound complexes 
were separated from unbound dsDNA using 6% Tris⋅boric acid-EDTA (TBE) gels 
with 0.25× TBE as a running buffer. The results were then visualized by scanning on 
a Typhoon imager (GE Healthcare; excitation at 488 nm; emission at 532 nm). FRET 
assays were also performed in a 384-well plate format using the Tecan M1000. All 
experiments were performed at least three times independent of one another, and 
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errors were calculated by using the SDs (number of independent experiments, n ≥ 
3). A Hill, quadratic, or competition form of binding equation were fit to the data 
using Kaleidagraph (Synergy Soft).  
2.4.4 Protein Labeling. 
IFI16 and IFI16HinAB were labeled using twofold molar excess of Dylight 550 
maleimide or Dylight 650 maleimide (Pierce) in buffer A with DTT replaced by 
TCEP. Labeling reactions were quenched by adding excess β-mercaptoethanol and 
the labeled-proteins were purified using Ni2+-NTA chromatography followed by 
size-exclusion chromatography. The labeling efficiency of IFI16 to each dye was 
approximately one to one, and there was no considerable difference in FRET data 
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In the innate immune system of mammals, supramolecular signalling 
platforms are directly assembled on intracellular foreign double-stranded (ds) DNA 
and RNA arising from invading pathogens (see refs [1] [2] [3] [4] [5] [6] for review). 
These supra-structures then induce the sequential polymerization of downstream 
effectors to propagate upstream signals [7] [8] [9] [10]. Though essential for 
defense against a number of pathogens such as Francisella tularensis and herpes 
simplex viruses [11] [12] [13] dysregulated foreign-nucleic acid-sensing pathways 
are associated with several autoimmune disorders including systemic lupus 
erythematosus and Sjögren's syndrome [14] [15] [16]. How the assembly of these 
large, complex structures is initiated on appropriate nucleic acids, and how the 
upstream ligand·receptor assemblies promote the sequential oligomerization of 
specific downstream effectors are two major unresolved mechanistic questions in 
understanding the foreign-nucleic acid-sensing pathways [5] [6]. Here, these 
fundamental questions in the assembly of the foreign-dsDNA-sensing filamentous 
superstructures by absent-in-melanoma-2 (AIM2) will be explored. 
AIM2 is the titular member of the AIM2-like receptor (ALR) family, which 
also includes other major foreign-dsDNA sensors such as interferon-inducible 
protein 16 (IFI16) [17] [18] [19] [20] [21]. ALRs directly assemble filamentous 
signalling platforms (the inflammasomes) on foreign dsDNA [7] [17] [19] [20] [18] 
[22] [23] [24]. For instance, AIM2 oligomerizes on cytosolic dsDNA and nucleates 
the polymerization of the adaptor protein ASC (apoptosis-associated speck-forming 
protein containing a CARD [caspase-recruiting domain]) filament, which then 
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nucleates the polymerization of the procaspase-1 filament; this final polymerization 
step activates caspase-1 via auto-proteolysis, triggering inflammatory responses 
including cytokine maturation and pyroptosis (Figure 3.1) [7] [8] [17] [19] [18] 
[20]. 
Many proteins build nucleoprotein filaments, frequently by classic RecA-like 
mechanisms [9] [10] [25] [26]. For instance, retinoic acid-inducible gene-I (Rig-I) 
and myeloid-differentiation-antigen-5 (MDA5) directly bind foreign dsRNA and 
assemble into filamentous signalling platforms using their RecA-like helicase 
domains [9] [10] [27] [28] [29]. However, ALRs are not RecA-like proteins, but 
consist of one oligomerization domain named pyrin domain (PYD) and one or two 
nonspecific dsDNA-binding HIN200 (hematopoietic interferon-inducible nuclear 
protein with 200 amino acids) domains (Figure 3.1) [30]. In contrast to Rig-I or 
MDA5 [9] [10] [27] [28] [29], the previous chapter’s study of IFI16 suggests that 
nucleic acid binding and polymerization are allosterically coupled in ALRs.  
There are two major unresolved questions regarding AIM2 inflammasome 
assembly. First, how AIM2 initiates the assembly is controversial. In contrast to the 
essential positive function of IFI16PYD in dsDNA binding and oligomerization [22], it 
was reported that the PYD of AIM2 (AIM2PYD) plays an autoinhibitory function by 
blocking the dsDNA-binding surface of HIN200 domain (AIM2Hin) [31] [32].  
Although it was recently reported that isolated AIM2PYD auto-assembles into 
filaments [7] [33], whether the filamentation activity has any role in dsDNA binding 
remains unknown. Second, although it has been established that AIM2PYD directly 
induces the polymerization of ASCPYD [7], how the recognition occurs at the 
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structural level remains speculative. For instance, many inflammatory signalling 
proteins contain PYDs and several highly conserved side chains that mediate 
multimeric PYD–PYD interactions have been identified [7] [33] [34]; however, only 
a subset of PYDs is known to interact with ASC [35] [36]. A recent study on foreign-
dsRNA-sensing pathways provides a potential mechanism, as Hur and colleagues 
discovered that congruent multimeric architectures underpin the sequential 
oligomerization in the Rig-I signalling pathway [9]. For instance, Rig-I recruits the 
CARDs of mitochondrial antiviral-signalling protein (MAVSCARD) into the helical 
‘oligomerization trajectory' of its CARD tetramers (Rig-ICARD), consequently 
providing a structural template for the polymerization of the MAVSCARD filament [9]. 
Wu and colleagues have determined the architecture of the filament assembled by 
the PYD of ASC (ASCPYD) [7]. However, because the architecture of AIM2PYD filament 
is unknown, it remains to be seen whether the AIM2–ASC axis operates in a similar 
manner. 
Here it is found that AIM2 is not autoinhibited, but the size of dsDNA can act 
as a ‘molecular ruler' to regulate the oligomerization of AIM2. Our collaborators also 
find that the helical symmetry of the AIM2PYD filament is consistent with that of 








       
Figure 3.1: A model for the assembly and activation of the AIM2 
inflammasome.  AIM2 is comprised of an N-terminal PYD that oligomerizes and a 
C-terminal dsDNA-binding HIN200 domain, with an unstructured 50-amino acid 
linker between the two.  ASC is a bipartite protein consisting of an N-terminal PYD 
and a C-terminal CARD.  Procaspase-1 contains an N-terminal CARD followed by the 






3.2.1 N-Terminal MBP Masks the Oligomerization Activity of AIM2 
No previous in vitro studies employed full-length AIM2 (AIM2FL) without 
additional protein tags. Even the cornerstone of the autoinhibitory model proposed 
by Xiao and colleagues is an observation where N-terminal maltose-binding protein 
(MBP)-tagged full-length AIM2 (AIM2FL) binds dsDNA more weakly than isolated 
AIM2Hin [31]. However, it was shown that N-terminal MBP masks the intrinsic 
oligomerization activity of PYDs by blocking a key interaction interface [7] [32] [33]. 
Thus, to re-examine the initiation of the AIM2 inflammasome assembly, 
recombinant AIM2FL and the isolated AIM2Hin in which N-terminal MBP tags are 
either left in place or removed by tobacco etch virus (TEV) protease were generated. 
The resulting AIM2 constructs all purify as monomers in gel filtration 
chromatography (Figure 3.2A,B). The binding affinity of MBP-tagged and -untagged 
AIM2 variants was compared by monitoring changes in fluorescence anisotropy of 
fluorescein amidite (FAM)-labelled 72-bp dsDNA (FAM-dsDNA72). 
MBP-AIM2FL bound FAM-dsDNA72 nearly twofold more tightly than MBP-
AIM2Hin (Figure 3.3A and Table 3.1). Without MBP, AIM2FL bound dsDNA72 at least 
20-fold more tightly than isolated AIM2Hin. Moreover, both tag-less AIM2 variants 
bound dsDNA72 significantly more tightly than their MBP-tagged counterparts 
(Figure 3.3A). Unlike the other AIM2 variants, the apparent binding constant of 
AIM2FL was near the concentration of ligand, suggesting that its binding to ligand is 
stronger than the lower limits of ligand concentrations used in the assays. These 
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data suggest that N-terminal MBP interferes with dsDNA binding of both AIM2FL and 
isolated AIM2Hin, and that AIM2PYD plays a major positive role in dsDNA binding by 
AIM2. 
Competition electrophoretic mobility shift assays with dsDNA fragments 
containing multiple AIM2Hin-binding sites can test whether the initiation of the AIM2 
inflammasome assembly on dsDNA proceeds via a two-state oligomerization 
binding mode [27] as opposed to the previously proposed non-interactive binding 
mechanism [31] [32]: no partially occupied intermediate dsDNA species are 
observed when a competitor is included in two-state oligomerization [27]. Here, 
both AIM2FL and isolated AIM2Hin showed an all-or-none transition; however, the 
MBP-tagged variants showed intermediates, further supporting a negative effect of 













             
Figure 3.2: Purification of AIM2 constructs by gel-filtration chromatography.   
The column used is indicated above the sample trace.  All elution volumes 
correspond to monomers according to the manufacturer’s guidelines (GE 
Healthcare). (A) Sample UV-visible absorbance trace of AIM2 FL.  To the right of the 
trace is a sample SDS-PAGE silver-stain gel of the combined peak fraction.  (B) 





                
Figure 3.3: Oligomerization is integral to dsDNA binding by AIM2.  (A) Binding 
of AIM2 variants to FAM-dsDNA72 (2.5nM) was monitored by changes in 
fluorescence anisotropy.  The lines are fits to a Hill form of binding isotherm.  The 
apparent binding constants (KD) are determined by the Hill equation (bound = 1/(1 
+ KDapp/[IFI16])Hill Coefficient) and the values are listed in Table 3.1.  All presented 
experiments were performed at least three times.  (B,C) Competition EMSAs in 
which increasing concentrations of dsDNA60 (190, 95, 45, 23, 12, 6, 3, and 




Variant KD (nM) Hill Coefficient 
MBP-AIM2FL 234 ± 42 1.4 ± 0.1 
MBP-AIM2 Hin  584 ± 22 1.1 ± 0.2 
AIM2 FL  ≤ 3 NA 
AIM2 Hin  212 ± 28 1.7 ± 0.2 
L10-11A-AIM2 FL  52 ± 11 1.7 ± 0.2 
Acidic Patch to Ala 37 ± 12 1.4 ± 0.2 
F27A-AIM2 FL  > 200 NA 
T50A-AIM2 FL 28  ± 7 NA 
K173A-AIM2 FL 113 ± 18 1.5 ± 0.3 
Q258A-AIM2 FL 37 ± 6 ND 
K272A-AIM2 FL 53 ± 13 1.7 ± 0.4 
E147A-AIM2 Hin ≥ 1500 ND 
F167A-AIM2 Hin ≥ 2000 ND 
K173A-AIM2 Hin ≥ 2500 ND 
K272A-AIM2 Hin ≥ 2500 ND 
Table 3.1. AIM2 constructs binding to FAM-dsDNA72 (160 mM KCl). ± indicates 















3.2.2 dsDNA Binding and Oligomerization are Integrated 
When dsDNA-binding is dependent on oligomerization, the apparent affinity 
toward ligand changes with the size of dsDNA [13]; this provides a test for AIM2. 
For instance, the apparent binding affinity would increase nonlinearly up to the 
‘optimal' oligomer dictated by nucleic acid sizes [27]. To characterize the DNA-
binding property of AIM2FL within the detection limit of the instruments, the 
reported salt concentration-dependent binding of AIM2Hin [31] was exploited and 
binding assays were performed with various dsDNA sizes at 400 mM KCl (Figure 
3.4, Table 3.2). Even in this high salt condition, AIM2FL robustly bound FAM-
dsDNA72 (Figure 3.4A). Importantly, AIM2FL bound larger dsDNA more tightly 
(Figure 3.4A), suggesting that oligomerization is integral to dsDNA binding. 
However, MBP-AIM2FL, MBP-AIM2Hin and AIM2Hin all showed no detectable binding 
in this high salt condition (Figure 3.4C, Table 3.3), again supporting the positive 
role of AIM2PYD in dsDNA binding. In 160-mM KCl, isolated AIM2Hin also bound the 
larger dsDNA more tightly (Figure 3.4B, Table 3.4). Finally, both AIM2FL and 
isolated AIM2Hin bound the footprint-size dsDNA (10 bp) with minimal affinity 
(Figure 3.4D), suggesting that oligomerization is important for high affinity binding 
of both AIM2 variants (the dsDNA-binding footprint of AIM2Hin is ∼9 bp [31] and 
that of AIM2FL is ∼12 bp, Figure 3.4E). 
Next, competition binding assays were performed to further investigate the 
relationship between dsDNA size and binding efficiency (dsDNA mass 
concentrations were used to normalize the number of available binding sites in each 
competitor; see Table 3.5, Table 3.6, Table 3.7). Consistent with the direct binding 
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data, both AIM2FL and isolated AIM2Hin bound larger dsDNA fragments significantly 
more tightly (Figure 3.5A,B). To allow isolated AIM2Hin to bind dsDNA, 160mM KCl 
was used; the dsDNA size-dependent binding was apparent for AIM2FL at both 400 
and 160 mM KCl, confirming that buffer salt concentrations do not alter the overall 
mechanism (Figure 3.5E,F). The plots of half-maximal inhibition (IC50) versus 
dsDNA size revealed a sigmoidal relationship where the difference in binding 
affinity between the near footprint-size dsDNA (dsDNA15) and dsDNA fragments 
larger than 300 bp can be as much as 4,000-fold for AIM2FL and 150-fold for AIM2Hin, 
respectively (Figure 3.5C,D). The cooperativity between the binding affinity and 
dsDNA size was assessed by using a Hill equation to fit the data (Figure 3.5C,D). 
The fitted Hill coefficient near four in Figure 3.5C suggests that the binding 
efficiency of AIM2FL would improve 10,000-fold when the size of dsDNA is increased 
by only 10-fold. Furthermore, about 70-bp dsDNA was required to exit the lag phase 
(‘threshold') and about 250- to 300-bp dsDNA fragments were required to achieve 
the ‘optimal' efficiency for generating AIM2FL·dsDNA complexes (Figure 3.5C). 
These dsDNA sizes in turn indicate that about 6 AIM2FL molecules are required to 
assemble a ‘threshold' oligomer and about 24 AIM2FL molecules will generate an 
‘optimal' oligomer (Figure 3.5C). The observed dsDNA size-dependent binding also 
correlates with a previous in vivo observation in which the interleukin-1β secretion 
activity increased cooperatively between 10 and 80 bp transfected dsDNA [31]. 
Overall, the ‘digitized' nucleoprotein complex-forming activity of AIM2 suggests that 
dsDNA can act as a ‘molecular ruler' to control the assembly of the inflammasome in 
a switch-like mechanism. 
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Figure 3.4:  dsDNA binding characterization of AIM2FL and isolated AIM2Hin. (A) 
Binding of AIM2FL and (B) isolated AIM2Hin to each FAM-labeled dsDNA (1.5 nM) 
was determined by fluorescence anisotropy.  The determined KD values are listed in 
Table 3.2 and Table 3.4. (C) Titration of MBP-AIM2FL, MBP-AIM2Hin, and AIM2Hin 
towards FAM-dsDNA72 (3 nM) in 400mM KCl.  (D) Titration of AIM2FL and isolated 
AIM2Hin to FAM-dsDNA10 (5 nM) in 160mM KCl.  (E) Stoichiometric titration of 
AIM2FL to 40 nM FAM-dsDNA60 and dsDNA72 in 160mM KCl to determine its 
footprint.  The inflection points were 210 and 213 nM for dsDNA60 and dsDNA72, 
respectively. 
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Figure 3.5: AIM2FL and isolated AIM2Hin bind dsDNA in a length-dependent 
manner. (A) Competition binding assays using FAM-dsVACV72 (1.5 nM, 0.06 
µg/ml) and AIM2FL (70 nM) at 400 mM KCl against various dsDNA fragments; the 
lines are fits to a competition binding equation: 1/(1+([DNAcompetitor]/IC50)^Hill 
Coefficient). The determined IC50 values are listed in Table 3.5.  (B) Competition 
binding assays using FAM-dsVACV72 (5 nM, 0.2µg/ml) and AIM2Hin (250 nM) at 160 
mM KCl against various DNA fragments. The determined values are listed in Table 
3.6.  The plots of the binding efficiency vs. the length of dsDNA for AIM2FL (C) and 
AIM2Hin (D). The binding efficiency was determined by normalizing the mean IC50 of 
each fragment to that of dsDNA600, and the data were fit to the Hill equation (the 
Hill coefficient for (C) is 4.2 ± 0.2 and (D) is 3.7 ± 0.3). The “threshold” oligomer is 
defined as the size of dsDNA (AIM2 cluster) required to exit the apparent lag phase, 
and the “optimal” oligomer is the size of dsDNA (AIM2 cluster) required to reach the 
inflection point. (E) Competition binding assays of AIM2FL (250 nM) and FAM-
dsDNA72 (5 nM) against various dsDNA at 160 mM KCl.  The determined KD are 
listed in Table 3.7.  (F) The relative binding efficient of AIM2FL with respect to the 
size of dsDNA from (E) was determined as in (C). 
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DNA Length (bp) KD (nM) Hill Coefficient 
24 ≥ 2000 ND 
39 531 ± 93 1.2 ± 0.1 
52 350 ± 12 1.1 ± 0.2 
72 39 ± 12 1.5 ± 0.3 
Table 3.2: Binding of AIM2FL towards various dsDNA lengths (400 mM KCl). ± 
indicates standard deviation.  n ≥ 3. 
 
 
Variant KD (nM) Hill Coefficient 
MBP-AIM2FL NB ND 
MBP-AIM2 Hin  NB ND 
AIM2 FL  39 ± 12 1.5 ± 0.3 
AIM2 Hin  NB ND 
L10-11A-AIM2 FL  NB ND 
Acidic Patch to Ala NB ND 
F27A-AIM2 FL  NB ND 
I46D- AIM2 FL NB ND 
T50A-AIM2 FL 95  ± 31 1.4 ± 0.1 
E147A-AIM2 FL 143 ± 45 1.4 ± 0.2 
F167A-AIM2 FL ND ND 
K173A-AIM2 FL ND ND 
Q258A-AIM2 FL 31 ± 5 1.4 ± 0.2 
Table 3.3. AIM2 constructs binding to FAM-dsDNA72 (400 mM KCl). ± indicates 
standard deviation.  n ≥ 3. 
 
 
DNA Length (bp) KD (nM) Hill Coefficient 
10 >> 2000 ND 
24 2110 ± 486 2.1 ± 0.4 
39 1205 ± 339 2.2 ± 0.5 
52 922 ± 168 1.4 ± 0.2 
72 212 ± 33 2.1 ± 0.4 
Table 3.4: Binding of AIM2Hin towards various dsDNA lengths (160 mM KCl). ± 







DNA Length (bp) IC50 (µg/mL) Hill Coefficient 
15 1695 ± 367 0.74 ± 0.17 
24 1608 ± 151 0.69 ± 0.26 
52 16 ± 6 0.97 ± 0.04 
60 6 ± 2 1.00 ± 0.10 
72 6.1 ± 1.8 1.17 ± 0.12 
100 3.1 ± 0.3 0.8 ± 0.3 
150 1.2 ± 0.3 1.5 ± 0.4 
300 0.39 ± 0.24 2.24 ± 0.16 
Table 3.5: AIM2FL competition binding (160 mM KCl). ± indicates standard 
deviation.  n ≥ 3. 
 
 
DNA Length (bp) IC50 (µg/mL) Hill Coefficient 
15 805 ± 118 1.3 ± 0.1 
24 365 ± 87 0.8 ± 0.3 
39 119 ± 32 0.7 ± 0.2 
52 31 ± 5 0.6 ± 0.2 
60 14 ± 1 0.9 ± 0.4 
72 25 ± 1 0.7 ± 0.1 
100 9.1 ± 0.7 1.2 ± 0.7 
150 4.1 ± 1.8 1.3 ± 0.3 
300 4.8 ± 0.5 1.5 ± 0.3 
600 5.3 ± 0.2 1.3 ± 0.1 
Table 3.6: AIM2Hin competition binding (160 mM KCl). ± indicates standard 
deviation.  n ≥ 3. 
 
DNA Length (bp) IC50 (µg/mL) Hill Coefficient 
15 328 ± 39 0.9 ± 0.4 
24 237 ± 67 0.8 ± 0.4 
39 16 ± 4 0.7 ± 0.3 
52 5.2 ± 0.5 0.8 ± 0.2 
60 2.6 ± 0.3 0.8 ± 0.1 
72 0.5 ± 0.1 0.8 ± 0.4 
100 0.29 ± 0.04 1.2 ± 0.1 
150 0.14 ± 0.01 1.5 ± 0.1 
300 0.09 ± 0.02 1.6 ± 0.1 
600 0.09 ± 0.02 1.4 ± 0.3 
Table 3.7: AIM2FL Competition Binding (400 mM KCl). ± indicates standard 
deviation.  n ≥ 3. 
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3.2.3 Mutagenesis Studies Support the Positive Role of AIM2PYD 
In the previous chapter, it was found that several highly conserved surface 
side chains of IFI16 mediate its oligomerization-driven dsDNA-binding mechanism 
(Figure 3.6A). For AIM2, several equivalently positioned surface side chains 
mediate the auto-oligomerization of isolated AIM2PYD in vivo [33] and interaction 
with ASCPYD in vitro [7](for example, Leu10, Leu11 and Phe27 in Figure 3.6B). 
However, whether these side chains have any role in dsDNA binding remains 
unknown. To further test the positive role of AIM2PYD in dsDNA binding, a panel of 
surface residue variants based on the study of IFI16 as well as sequence 
conservation (Figure 3.6A,B; none of these side chains are implicated in the alleged 
autoinhibition of AIM2 [31] [32], see also below) was generated. Almost all of these 
PYD variants significantly disrupted the dsDNA-binding activity of AIM2FL (Figure 
3.6C), supporting that oligomerization of PYD plays a major positive function in 
dsDNA binding. 
Xiao and colleagues proposed that a unique acidic surface of AIM2PYD not 
present in other related ALR docks to the basic dsDNA-binding surface of AIM2Hin, 
thus stabilizing the autoinhibited conformation in the absence of dsDNA [31] [32] 
(Figure 3.6A,B; designated ‘acidic patch'; Asp19, Glu20, Glu21 and Asp23). Such an 
autoinhibitory model entails that neutralizing the acidic patch would allow AIM2FL 
to bind dsDNA more tightly. However, D19A-E20A-E21A-D23A-AIM2FL failed to 
bind FAM-dsDNA72 (Figure 3.6C). This observation disagrees with the inhibitory 
role of the acidic patch, but is again consistent with the idea that AIM2PYD plays a 





Figure 3.6: Mutagenesis studies to test the role of AIM2PYD in dsDNA binding. 
(A) The sequence alignment of ALRs. The side-chains mutated here are indicated in 
red. (B) The crystal structure of AIM2PYD (PDB ID: 3VD8). The mutated side-chains 
are shown as spheres. The amino acids indicated in the parentheses are the 
equivalent IFI16 residues. (C) Binding of FAM-dsDNA72 (1.5 nM) by various AIM2FL 








3.2.4 The oligomerization of AIM2Hin is shared with murine p202 
In contrast to the dsDNA-binding HIN200 domains of IFI16, these dsDNA-
binding studies suggest that AIM2Hin alone can oligomerize on dsDNA (Figure 3.4B 
and Figure 3.5B,D). On the other hand, a murine ALR named p202 inhibits the 
activity of AIM2 by binding to AIM2Hin with its tetrameric second HIN200 domain 
(p202HinB); p202HinB does not bind dsDNA [37]. Several p202HinB side chains 
implicated in tetramerization [37] are conserved in AIM2Hin (Figure 3.7A,B). To test 
whether AIM2Hin uses similarly positioned side chains as p202HinB to cluster on 
dsDNA, the indicated side chains in Figure 3.7A,B were mutated on both AIM2FL 
and isolated AIM2Hin. Mutations distal to the dsDNA-binding surface significantly 
decreased dsDNA binding by both AIM2FL and AIM2Hin (Figure 3.7C,D). These 
results not only support the idea that the oligomerization of AIM2Hin is important for 
dsDNA binding but also suggest that the oligomerization of AIM2Hin is an 












Figure 3.7: Mutagenesis studies to test the evolutionarily conserved 
oligomerization activity AIM2Hin in dsDNA binding. (A) The sequence alignment 
of AIM2Hin and p202HinB. The side-chains mutated here are indicated in red. (B) The 
crystal structure of dsDNA-bound AIM2Hin (colored in “wheat;” PDB ID: 3RN2) 
aligned to the tetramer structure of p202HinB (PDB ID: 4L5T); root mean squared 
deviation of alignment is 1.5Å. The p202HinB protomers are colored in green, yellow, 
pink, and cyan, respectively. The mutated side-chains are shown as spheres. AIM2 
side-chains are labeled in black and those from p202 are indicated in cyan. (C) 
Binding of FAM-dsDNA72 (1.5 nM) by various AIM2FL HIN200-mutants were tested 
at 400 mM KCl. The determined KD values are listed in Table 3.3. (D) Binding of 
various AIM2Hin mutants were tested on FAM-dsDNA72 (5 nM) at 160 mM KCl. The 
determined KD values are listed in Table 3.1. 
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3.2.5 AIM2PYD is required to oligomerize when dsDNA is in excess 
When basal AIM2 encounters foreign dsDNA in the cytoplasm, the individual 
molecules must assemble into the inflammasome even in the presence of excess 
binding sites (for example, nearly 400,000 binding sites are in the genome of one F. 
tularensis). To test this idea, two separate AIM2FL populations were labeled with a 
Förster resonance energy transfer (FRET) donor and acceptor (Figure 3.8A, top). 
As previously observed for full-length IFI16, saturating FRET signals were indeed 
detected from AIM2FL in a dsDNA size-dependent manner even when the substrate 
is present in excess (Figure 3.8A,B; Table 3.8). FRET signals were detected from 
dsDNA fragments as short as 24 bp, suggesting that the minimal binding unit for 
AIM2 oligomerization is a dimer compared with a tetramer for IFI16 (see previous 
chapter). Consistent with the competition assays (Figure 3.5), plotting the 
normalized binding efficiency versus dsDNA length from the FRET assay data also 
suggests a cooperative relationship in which the binding affinity of AIM2FL can 
increase as much as 1,000-fold when the size of available dsDNA is 10 times longer 
(the Hill coefficient is ∼3; Figure 3.8C). FRET signals from labelled AIM2Hin were 
only detected if the salt concentration of the reaction buffer was lowered to 60 mM 
KCl (Figure 3.8D). Unlike AIM2FL, FRET signals from labelled AIM2Hin peaked at the 
dsDNA concentration equivalent to the amount of AIM2Hin present in these assays, 
but decreased with excess dsDNA (Figure 3.8D). Also, unlike AIM2FL, the peak 
amplitude was correlated with the size of each dsDNA (Figure 3.8D). These 
observations suggest that the AIM2Hin oligomers are likely different from those 
assembled by AIM2FL, and that AIM2PYD is required for robust dsDNA binding and 
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polymerization in the presence of excess dsDNA. In addition, the observed 
cooperative relationship between dsDNA size and oligomerization activity (Figure 
3.8C) is consistent not only with the competition experiments (Figure 3.5C) but 
also with the previous in vivo observation [31], thus further supporting a ‘digital 






















Figure 3.8: AIM2PYD is necessary for oligomerization and dsDNA binding in the 
presence of excess dsDNA. (A) Top: a cartoon demonstrating the rationale of the 
described FRET experiments. The two differentially colored ovals represent 
fluorophore (Dylight-550 and Dylight-650) labeled AIM2. Bottom: A sample 
fluorescence emission spectra of an equimolar mixture of FRET donor and acceptor 
labeled AIM2FL. A.U., arbitrary units.  (B) Changes in the ratio between the FRET 
donor emission (λmax: 578 nm) and the acceptor emission (λmax: 678 nm) at each 
indicated dsDNA concentration. The apparent oligomerization constants (KDF) were 
obtained by fitting the data to a Hill equation and are listed in Table 3.8. (C) A plot of 
binding efficiency vs. the length of dsDNA for AIM2FL. The data were fit to the Hill 
equation (the Hill coefficient is 3.2 ± 0.3). The efficiency was determined by 
normalizing the mean KDF of each fragment to that of dsDNA600. (D) The FRET ratio 
of AIM2Hin with increasing amounts of various dsDNA. The red arrow indicates the 
concentration of AIM2Hin present in the assay. 
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DNA Length (bp) KD (µg/mL) Hill Coefficient 
24 1.75 ± 0.57 0.9 ± 0.1 
39 0.16 ± 0.01 1.4 ± 0.4 
52 0.32 ± 0.01 1.9 ± 0.3 
60 0.23 ± 0.06 1.6 ± 0.3 
72 0.18 ± 0.02 2.1 ± 0.4 
100 0.12 ± 0.02 1.6 ± 0.1 
150 0.08 ± 0.01 1.5 ± 0.2 
200 0.07 ± 0.02 1.5 ± 0.2 
300 0.07 ± 0.02 1.2 ± 0.2 
600 0.07 ± 0.01 2.6 ± 0.7 



















3.2.6 apo-AIM2FL can auto-oligomerize 
The autoinhibitory model entails that dsDNA is required to unlock 
monomeric AIM2 and initiate oligomerization [31] [32]. By contrast, because 
untagged AIM2FL binds dsDNA much more tightly than AIM2Hin, the role of dsDNA 
may be to increase the local concentration of AIM2 by acting as a ‘one-dimensional 
ruler,' consequently improving the prospects for forming AIM2PYD·AIM2PYD 
encounter complexes. This model entails that dsDNA-free AIM2FL should be able to 
oligomerize on its own if the concentration threshold is met. On the other hand, apo-
AIM2FL should remain monomeric according to the autoinhibitory model. To test 
these opposing predictions, negative stain electron microscopy (ns-EM) was used to 
probe the oligomeric state of apo-AIM2FL at various concentrations. Disagreeing 
with the autoinhibitory model, apo-AIM2FL forms filaments (Figure 3.9A) in a 
protein concentration-dependent manner (≥1 μM; Figure 3.9D). Closer inspection 
of the electron micrographs revealed that DNA-free AIM2FL filaments assume 
‘Brussels Sprout'-like structures in which the central filaments (‘core stems') are 
decorated with speck-like densities at the periphery (‘sprouts') (Figure 3.9C). 
Although the core stem appeared well ordered, the peripheral specks appeared 
random and often disordered (Figure 3.9A,C,D,E). On the basis of the reported 
auto-filamentation activity of isolated AIM2PYD [7] [33], it is likely that AIM2PYD 
forms the core stem and the AIM2Hin clusters are flexibly attached via the 
intrinsically disordered linker region (50 amino acids); the 9-nm diameter of the 
core stem also corresponds to the width of the ASCPYD filament [7].  In addition, no 
auto-assembled AIM2Hin filaments were observed (Figure 3.9B). AIM2FL filaments 
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were detected even at 1.6 M NaCl, thus suggesting that they are more resilient 
against the environment than the ASCPYD filament [7] (Figure 3.9E). Considering 
this auto-oligomerization activity, the concentrations of wild-type AIM2FL were kept 
as low as possible in the biochemical assays (typically <100 nM; Figures 3.3-3.8). 
Moreover, saturating binding isotherms were observed in most of the assays 



















     
 
Figure 3.9: AIM2FL assembles into filaments without dsDNA. (A) A negatively 
stained electron micrograph of AIM2FL at 2 µM. (B) A negatively stained electron 
micrograph of AIM2Hin at 5 µM. (C) Higher magnification of the AIM2 filament. The 
inset is unpicked Brussels sprout, and the cartoon on the right is the proposed 
overall arrangement of the filament. The red box in C indicates the stable “core 
stem” of the AIM2FL filament. (D) Electron micrographs of AIM2FL at various 
concentrations.  The scale bar is 500 nm. (E) Electron micrographs of AIM2FL  (2 µM) 
at various salt concentrations.  The scale bar is 100 nm. 
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3.2.7 dsDNA-binding deficient variants fail to auto-oligomerize 
If the AIM2 variants identified in the present study indeed affect 
oligomerization, but not direct protein–dsDNA interactions, they should also disrupt 
the auto-filamentation activity. Hence, these variants were subjected to examination 
using ns-EM. The Brussels sprout-like filaments were detected from the AIM2FL 
variants that lacked any major defects in dsDNA binding (Figure 3-10). However, 
the AIM2FL variants with impaired dsDNA binding did not show any auto-assembled 
filaments regardless of whether a mutation is located on the PYD or HIN200 
domains (Figure 3-10). The failure to auto-assemble by mutating the PYD side 
chains suggests that it is the filamentation activity of AIM2PYD that positively 
contributes to dsDNA binding. Moreover, the lack of auto-oligomerization resulting 
from mutating the HIN200 domain side chains suggests that although the 
oligomerization activity of AIM2PYD outweighs that of AIM2Hin, both domains have 












Figure 3.10: Select mutations disrupt AIM2 auto-filaments.  Shown are electron 




3.2.8 Helical symmetry of the AIM2PYD filament 
Several previous studies reported the direct interaction between AIM2PYD 
and ASCPYD [7] [17] [20]. The helical architecture of the ASCPYD filament is known 
[7]; however, whether or not the upstream AIM2 oligomer provides a 
‘polymerization template ' via a congruent oligomeric architecture as seen from the 
Rig-I·MAVS interaction [9] is an open question. Thus, our collaborator Edward 
Egelman determined the helical symmetry of the core stem of the AIM2FL filaments. 
The average power spectrum of the AIM2FL filaments obtained from ns-EM is 
remarkably similar to that of the ASCPYD filament (Figure 3.11A, see also ref. [7]), 
which is an ∼90-Å wide, six-start helix with three-fold symmetry [7]. These 
parameters also agree with the proposition in which the AIM2PYD filament 
constitutes the core stem (Figure 3.9C). On the basis of the consistent helical 
symmetry, a homology model of the AIM2PYD filament was generated using the cryo-
EM structure of the ASCPYD filament as a template [7], where it was found that all the 
side chains identified to be important for dsDNA binding and auto-oligomerization 
are located at the subunit interfaces (Figure 3.11B,C). Overall, the EM analysis 
suggests that the upstream AIM2PYD filament provides a structural template for the 








Figure 3-11: The congruent helical symmetry between filaments assembled by 
AIM2PYD and ASCPYD. (A) The ns-EM average power-spectra of the AIM2PYD filament 
(left) and the ASCPYD filament (right; unpublished, courtesy of Dr. Hao Wu, Harvard). 
The colored arrows indicate corresponding helical symmetry lines observed from 
both filaments.  (B and C) A homology of model of the AIM2PYD filament based on the 
cryo-EM structure of the ASCPYD filament (PDB ID: 3J63). The AIM2 side-chains 




3.2.9 PYD interactions dictate the filament architecture 
A previous cell-based imaging study showed that isolated AIM2PYD and 
AIM2FL form filamentous aggregates, but AIM2Hin failed to form such structures [33]; 
whether dsDNA (transfected plasmid) is part of the filamentous AIM2FL aggregates 
is unknown. The present study is consistent with this in vivo observation [33], as 
dsDNA-free AIM2FL assembles into filaments via its PYD. However, in principle, the 
HIN200 domains of AIM2FL could bind dsDNA along its length, and thus might also 
generate an ordered filamentous structure. Thus, to further resolve whether 
AIM2PYD or AIM2Hin oligomers dictate the overall architecture of dsDNA-bound 
AIM2FL, the morphologies of AIM2FL and AIM2Hin bound to λ-phage dsDNA (λdsDNA) 
were determined using ns-EM. Isolated AIM2Hin did not show any ordered filaments, 
but displayed random ‘beads on a string'-like clusters on λdsDNA (Figure 3.12A). 
By contrast, the Brussels sprout-like filaments were no longer detected on adding 
dsDNA to AIM2FL, but new larger filaments about two- to three-times wider than the 
DNA-free filaments appeared in the micrographs (20–25 nm; Figure 3.12B), 
indicating dsDNA binding. Together, these observations suggest that AIM2Hin binds 
dsDNA and clusters randomly, and that AIM2PYD oligomers underpin the filamentous 
architecture of dsDNA-bound AIM2FL. 
λdsDNA is about 50 kb and displayed random-coil structures (Figure 3.12B); 
however, all observed dsDNA-bound AIM2FL filaments seemed well ordered, further 
suggesting that PYD–PYD interactions, but not AIM2Hin–dsDNA interactions (Figure 
3.12A,B), dictate the overall architecture of λdsDNA-bound AIM2FL filaments. 
Because unbound λdsDNA can be observed in the AIM2FL·dsDNA samples (Figure 
 94 
3.12B), the EM experiments also reveal that AIM2FL filaments assemble from 
random positions on dsDNA and that the filaments can assemble even in the 
presence of excess dsDNA (Figure 3.12B). These results not only corroborate the 
FRET assays in which AIM2FL oligomerized in the presence of excess dsDNA (Figure 
3.8) but also are consistent with the oligomerization activity of IFI16, which also 
formed filaments in the presence of excess dsDNA via its PYD (see previous 
chapter). Several filaments apparently merged laterally and became intertwined, 
likely reflecting the punctate-like AIM2 inflammasome structures observed from in 
vivo studies [20] [31] (Figure 3.12C,D).  
To further test that AIM2PYD oligomers, but not those assembled by AIM2Hin, 
underpin the filamentous structure of dsDNA-bound AIM2FL, the morphologies of 
several λdsDNA-bound AIM2FL variants with defective dsDNA-binding/auto-
assembly activities were examined. Conditions that allow these AIM2FL variants to 
bind dsDNA were identified (160 mM KCl; same as all wild-type EM experiments); 
all the defective variants still bound dsDNA significantly more weakly than wild type 
(Table 3.1). Under these conditions, disrupting the oligomerization activity of 
AIM2Hin still allowed the full-length protein to assemble into isomorphic filaments 
on λdsDNA as wild type (Figure 3.12E–G). The I46D mutation located in the PYD 
also resulted in wild type-like AIM2FL filaments once bound to λdsDNA (Figure 
3.12H). However, L10A-L11A-AIM2FL showed a heterogeneous nucleoprotein 
filament population (Figure 3.12I). More strikingly, D19A-E20A-E21A-D23A-
AIM2FL (acidic patch) displayed disordered clusters similar to λdsDNA-bound 
isolated AIM2Hin (Figure 3.12J). The homology model indicates that Leu10, Leu11 
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and Ile46 mediate the radial interactions in the AIM2PYD filament, while the acidic 
patch mediates the axial interactions (Figure 3.11B and Figure 3.12K). Thus, these 
results suggest that the dsDNA scaffold can at least partially restore the filamentous 
structure if the radial interactions in the AIM2PYD filament are compromised (Figure 
3.11B and Figure 3.12K). However, disrupting the axial interactions seems to be 
detrimental to the filamentous structure even when bound to the dsDNA scaffold 
(Figure 3.11B and Figure 3.12K). In reviewing the previous experiments, it 
appears that filamentous AIM2PYD oligomers underpin the architecture of dsDNA-




Figure 3.12: AIM2PYD is required to assemble filamentous structures on 
dsDNA. (A) An electron micrograph of AIM2Hin clusters on λ-phage dsDNA. (B-D) 
Electron micrographs of wild-type AIM2FL filaments assembled on λ-phage dsDNA. 
(E-J) Electron micrographs of AIM2FL mutants bound to λ-phage dsDNA. (K) A 
cartoon of the AIM2PYD filament and the locations of mutated side-chains based on 




Presented here is evidence supporting an oligomerization-driven activation 
mechanism for initiating the assembly of the AIM2 inflammasome in the absence of 
the currently prevailing autoinhibitory mechanism [31] [32] (Figure 3.13). For 
instance, the basal concentration of AIM2 is presumably low nanomolar under 
normal conditions, but is dramatically raised on pathogenic invasion (AIM2 is 
overexpressed by type-1 interferons by at least 200-fold) [19] [20] [38]. The model 
presented here predicts that, in the absence of cytosolic dsDNA, AIM2 would fail to 
oligomerize and induce the polymerization of ASC due to its low basal 
concentration. For instance, in physiologically relevant reaction conditions, AIM2 
can assemble into a filament on dsDNA larger than 300 bp even at pico-molar 
concentrations, but it requires nearly 10,000-fold more AIM2 molecules to auto-
assemble filaments without dsDNA (Figure 3.5 and Figure 3.8). On the other hand, 
because oligomerization is coupled with dsDNA binding, individual AIM2 molecules 
are capable of finding one another even in the presence of excess dsDNA (Figure 
3.8). Thus, when foreign dsDNA invades, basal AIM2 would rapidly cluster into a 
seed filament necessary to nucleate the polymerization of ASC. 
The assembly of Rig-I and MDA5 filaments on foreign dsRNA is intrinsically 
regulated by the ATP turnover at their helicase domains [27] [28] [29]; the filament 
assembly of Rig-I is further regulated by the recognition of 5′-triphosphate of dsRNA 
[1] [29]. However, ALRs lack any dsDNA sequence specificity and auto-assemble 
into filaments without any cofactors [30]. These observations raise the question of 
whether ALRs are regulated at all. The dsDNA length-dependent binding may 
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provide a key to answering this question. Although MDA5 can assemble into 
filaments along the length of dsRNA, the ability to discriminate between ‘short' and 
‘long' dsRNA by MDA5 is not as pronounced as that of AIM2 or IFI16 [27], as if 
separating the ligand-binding domain from the polymerization domain generates 
greater dependence on the size of the nucleic acid scaffold for assembly. ‘Long,' 
naked cytosolic dsDNA is rare, and Knipe and colleagues postulated that IFI16 
would selectively recognize foreign dsDNA by the degree of chromatinization [12] 
[39] [40]. Indeed, the highly cooperative relationship between the binding affinity 
and the size of dsDNA can clearly define an ‘off' and ‘on' state for assembling the 
AIM2 nucleoprotein filament (Figure 3.5 and Figure 3.8). Moreover, the size of 
dsDNA required to build the ‘threshold oligomer' (Figure 3.5 and Figure 3.8) also 
correlates with a previous in vivo study in which about 80-bp cytosolic dsDNA was 
required to induce robust interleukin-1β secretion [31]. Taken together, these data 
suggest that the size of dsDNA can act as a powerful ‘molecular ruler' that can 
regulate the initiation of the AIM2 inflammasome assembly in a switch-like 
mechanism. 
Unlike the HIN200 domains of IFI16 (see previous chapter), AIM2Hin 
oligomerizes on dsDNA, which appears to be at least partially responsible for the 
more robust dsDNA-binding activity of AIM2 than IFI16 in vitro [31]. It is tempting 
to speculate that the oligomerization of AIM2Hin has not been selected against 
because cytosolic AIM2 is much less likely to encounter self-dsDNA than nuclear 
IFI16. On the other hand, p202HinB does not bind dsDNA, but forms a tetramer that 
prevents AIM2 from clustering on dsDNA [37]. The oligomerization activity of 
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AIM2Hin further strengthens this finding, as p202HinB would physically interfere with 
clustering of AIM2Hin on dsDNA. Moreover, not all the side chains implicated in the 
tetramerization of p202HinB are conserved in AIM2 [37] (Figure 3.7A,B), thus 
preventing spurious auto-oligomerization. Nevertheless, the above experiments 
show that isolated AIM2Hin oligomerizes into random clusters on dsDNA without 
any filamentous architecture (Figure 3.12A) and that disrupting the 
oligomerization of AIM2Hin still results in filaments isomorphic to wild type (Figure 
3.12E–G). Thus, the role of AIM2Hin oligomerization is essential, yet limited to 
generating a ‘seed' nucleation unit preceding the filament growth (Figure 3.13). 
AIM2 is overexpressed by type-1 interferon pathways on pathogenic 
invasion [30] [38]. The finding of auto-assembly suggest that in principle, dsDNA 
binding is not a priori required to initiate assembly.  The auto-oligomerization of 
AIM2 (Figure 3.9) may also enhance the host defense response (Figure 3.13). For 
example, the pre-assembled AIM2 platforms would be able to survey the cytoplasm 
more effectively because of the larger contiguous surface area. The AIM2Hin clusters 
could also increase the dsDNA-binding activity via avidity, and the AIM2 oligomers 
would immediately nucleate the polymerization of ASC without binding foreign 
dsDNA. However, this could be a double-edged sword: the auto-oligomerization 
activity of AIM2 could also underlie several autoimmune disorders in which AIM2 is 
overexpressed via hyperactive interferon pathways [14] [15] [16], as it could cause 
persistent inflammasome activity without any pathogenic dsDNA. 
The symmetry of the AIM2 filament suggests the structure–activity 
relationships in the assembly. For instance, the three-fold symmetry of the six-start 
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helix correlates with the dimeric minimal binding unit of AIM2 observed in the 
FRET assays (Figure 3.8B,C; 2 × 3=6). The requirement for clustering about six 
AIM2 molecules (Figure 3.5C and Figure 3.8C) to generate a robust ‘threshold 
oligomer' also correlates with one hexameric base of the six-start helix. 
Furthermore, the optimal oligomer size of 20–25 AIM2 molecules (Figure 3.5C and 
Figure 3.8C) also suggests that about four hexameric rings may need to stack up to 
assemble an optimally stable AIM2 nucleoprotein filament. Finally, because the 
ASCPYD filament also has the same helical architecture as the AIM2PYD filament, it is 
tempting to speculate that the assembly of the upstream filament is directly coupled 
to the downstream effector activation, thus achieving maximal cooperativity. 
Both PYDs and CARDs belong to the death-domain (DD) superfamily [35] 
[41]. Despite their widely variable primary sequences, all known CARDs and PYDs 
share essentially the same tertiary structure (six-helix bundles) [35] [42]. Several 
DD proteins are capable of assembling into helical filaments [7] [10] [42], and the 
PYDs are mostly distinguished from the CARDs by one extended loop region 
between helices 2 and 3 [35] [41]. Thus, a major outstanding question regarding the 
signalling mechanism of both PYDs and CARDs has been how one DD protein 
specifically selects its interacting partner. Although all DD proteins utilize 
essentially the same set of interaction surfaces for oligomerization [35] [41], it is 
becoming clear that the resulting oligomers display vastly diverse helical 
architectures [7] [10] [42]. Indeed, it was recently shown that identical helical 
symmetry underlies the mechanism by which the Rig-ICARD tetramers nucleate the 
MAVSCARD filament [10]. It had yet to be tested whether such a symmetric 
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interaction is a unifying theme in assembling filamentous supramolecular signalling 
platforms by both CARDs and PYDs, especially when both upstream and 
downstream DD domains can assemble into infinite filaments as observed from 
AIM2 and ASC. The consistent helical symmetry between the AIM2PYD and ASCPYD 
filaments suggests that the corresponding polymerization trajectory between the 
upstream and downstream oligomers not only underpins the assembly of the 



















Figure 3.13: A model for the assembly of the AIM2 inflammasome. AIM2PYD is 
not auto-regulated. Depending on its cellular concentration, auto-assembly or 
dsDNA-mediated assembly will drive the initial filament formation. Importantly, 
basal AIM2 requires large dsDNA to generate energetically stable nucleoprotein 
complexes, because oligomerization is integral to dsDNA binding. The 
oligomerization of AIM2Hin is important for auto- or dsDNA-mediated filament 
assembly, but the construction of the filamentous architecture is dictated by 
AIM2PYD. The resulting AIM2 filaments then nucleate the assembly of the ASC 
filaments via corresponding helical architecture (ASCCARD is not shown in the 









All DNA below 90 bp were purchased from Integrated DNA Technologies, and 
DNA of greater length was synthesized by PCR. FAM-labelled DNA was also 
purchased from Integrated DNA Technologies. DyLight-550 and DyLight-650 
maleimides were purchased from Thermo. 
3.4.2 Recombinant AIM2 constructs. 
Full-length AIM2 variants (residues 1–343) were cloned into a pET21 vector 
(Novagen) with a modified N-terminal MBP tag with a TEV protease recognition site. 
HIN200 variants (residues 144–343) were cloned into a pET28 vector with a 
modified N-terminal small ubiquitin-like modifier (SUMO) protein tag or the 
previously described pET21 vector for assays including an MBP tag. All clones were 
transformed into Escherichia coli strain ER2566 (NEB). Cells were grown at 37 °C to 
OD600 0.4–0.7, induced with 0.2 mM isopropyl β-D-1-thiogalactopyranoside, 
expressed for at least 15 h at 18 °C, and then harvested. 
For purification of unlabelled protein, cell pellets were resuspended in 
20 mM HEPES pH 7.4, 400 mM NaCl, 5% glycerol, 1 mM EDTA and 1 mM 
dithiothreitol (DTT) while SUMO-tagged construct cell pellets were resuspended in 
20 mM HEPES pH 7.4, 400 mM NaCl, 5% glycerol, 20 mM imidazole and 3 mM beta-
mercaptoethanolamine (βME); a protease cocktail consisting of phenylmethyl 
sulfonyl fluoride, benzamidine, leupeptin and pepstatin A was added, as well as 
lysozyme and DNase I. Cells were lysed by sonication and the insoluble fraction was 
removed by centrifugation. The supernatants were applied to amylose resin (NEB) 
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for MBP-tagged constructs or Ni-NTA resin (QIAgen) for SUMO-tagged constructs. A 
wash of 10–15 CV of resuspension buffer was applied, and then the protein was 
eluted in either 20 mM HEPES pH 7.4, 120 mM NaCl, 2% glycerol, 30 mM maltose 
and 3 mM βME for MBP-tagged or 20 mM HEPES pH 7.4, 120 mM NaCl, 2% glycerol, 
300 mM imidazole and 3 mM βME for SUMO-tagged constructs. The elution was then 
applied to a HiTrap-SP Column (GE Healthcare) and the protein eluted off a gradient 
of 20 mM HEPES pH 7.4, 120 mM–1M NaCl, 2% glycerol and 3 mM βME. Fractions 
containing highly purified protein were collected. For biochemical assays using 
MBP-tagged protein, these fractions were then applied to a Superdex200 16/600 
gel-filtration column (GE Healthcare) equilibrated in 20 mM HEPES pH 7.4, 400 mM 
KCl, 2% glycerol, 1 mM EDTA and 1 mM DTT. For biochemical assays using untagged 
protein, the pooled fractions were diluted 10-fold with 20 mM HEPES pH 7.4, 
750 mM NaCl, 2% glycerol, 20 mM imidazole and 3 mM βME, and TEV (MBP tag) or 
Ulp-1 (SUMO tag) was added, and the solution was dialysed at least 15 h against 
20 mM HEPES pH 7.4, 120 mM NaCl, 2% glycerol, 20 mM imidazole and 3 mM βME. 
For full length, the solution was then re-applied to the HiTrap-SP column, and then 
eluted off in tandem with a HisTrap-FF (GE Healthcare) with 20 mM HEPES pH 7.4, 
750 mM NaCl, 2% glycerol, 20 mM imidazole and 3 mM βME. For HIN200, the 
solution was applied to a HisTrap-FF column in tandem with a HiTrap-SP column, 
the HisTrap column was then removed and the protein was eluted from the HiTrap 
column in the same buffer as the full length. The elution fractions were applied 
directly to a Superdex75 16/600 gel-filtration column (GE Healthcare) equilibrated 
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in 20 mM HEPES pH 7.4, 400 mM KCl, 2% glycerol, 1 mM EDTA and 1 mM DTT. 
Fractions containing the protein were then concentrated. 
For fluorescent labelling of proteins, after elution from their respective 
affinity columns, they were applied to a HiTrap-SP column and eluted using a 
gradient of 20 mM HEPES pH 7.4, 120 mM NaCl–1M NaCl, 2% glycerol and 1 mM 
TCEP. The solution was then divided into two, and to one was added DyLight-550 at 
a concentration of 4 × (AIM2) and to the other was added DyLight-650 at a 
concentration of 4 × (AIM2). Labelling proceeded for at least 15 h. Excess dye was 
quenched using 10 mM βME, and the solution was re-applied to their respective 
affinity columns. After extensive washing with 20 mM HEPES pH 7.4, 750 mM NaCl, 
2% glycerol and 3 mM βME until no fluorescence could be detected in the flow 
through, the protein was eluted in wash buffer supplemented with either 30 mM 
maltose (full length) or 300 mM imidazole (HIN200). Cleavage and further 
purification proceeded as above. The dye:protein ratio was then calculated as per 
the manufacturer's instructions, which was ∼1:1. 
3.4.3 Biochemical assays. 
All experiments were performed at least three times, the fits to data were 
generated by Kaleidagraph software (Synergy). Fluorescence anisotropy-binding 
experiments were carried out in either 40 mM HEPES pH 7.4, 160 mM KCl, 5% 
glycerol, 0.1% Triton X-100, 1 mM EDTA, 5 mM DTT (herein referred to as ‘buffer A') 
or 40 mM HEPES pH 7.4, 400 mM KCl, 5% glycerol, 0.1% Triton X-100, 1 mM EDTA 
and 5 mM DTT (herein referred to as ‘buffer B') at room temperature as described in 
the previous chapter. 
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Förster resonance energy transfer experiments were carried out in either 
buffer A (for AIM2FL and AIM2Hin) or buffer C (40 mM HEPES pH 7.4, 60 mM KCl, 5% 
glycerol, 0.1% Triton X-100, 1 mM EDTA and 5 mM DTT) for AIM2Hin as described in 
the previous chapter. 
Electrophoretic mobility shift assay experiments were carried out in buffer A. 
To a fixed amount of fluorescein-labelled dsVACV72 was added increasing 
concentrations of AIM2. The reaction was allowed to equilibrate at room 
temperature (at least 20 min), then applied to a 4% 116:1 acrylamide:bis-
acrylamide Tris-borate-EDTA gel. The gel was run at 100 V in 1 × Tris-borate-EDTA 
buffer and imaged using a Typhoon imager (GE Healthcare; excitation at 488 nm, 
emission at 532 nm). 
3.4.4 Electron microscopy. 
AIM2 samples were adsorbed to glow-discharged carbon grids for 2 min, 
then blotted and transferred through two consecutive drops of 1% uranyl formate 
or 1% uranyl acetate for a total of 1–2 min. The carbon film was then quickly dried 
by aspiration. Images were collected with either a Philips BioTwin CM120 (FEI) at 
Johns Hopkins School of Medicine or Tecnai 12 at University of Virginia. For the 
dsDNA·AIM2 complexes, λdsDNA and AIM2 constructs were incubated 30 min 
before EM sample preparation. The linearized plasmid was generated by digesting 
the pET28b vector (Novagen) with BamH1 (NEB). The nicked circle was generated 




3.4.5 Homology modeling. 
The crystal structure of AIM2PYD (PDB ID: 3VD8) was aligned to individual 
protomers of the cryo-EM structure of the ASCPYD filament (PDB ID: 3J63) using 
Pymol (The PyMOL Molecular Graphics System, Version 1.7.4 Schrödinger, LLC). The 
root mean squared deviation of the individual alignment is <1 Å. 
3.4.6 Symmetry determination. 
Micrographs of negatively stained AIM2FL filaments were scanned using a 
Nikon CoolPix 8000 with a raster of 4.16 Å/pixel. Filaments were extracted using 
the e2helixboxer routine within EMAN2 [43], and the SPIDER software package [44] 
was used for subsequent steps. Overlapping boxes 96 pixels long were cut from 
these filaments, and 7,607 boxes were aligned against a preliminary reconstruction 
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The host innate immune system detects infection by directly recognizing 
molecular signatures associated with pathogens [1] [2]. Remarkably, such 
signatures include universal building blocks of all life, such as DNA and RNA [3] [4] 
[5]. In the cytoplasm, the immune system relies on the absence of endogenous DNA, 
and thus marks all detected DNA as “foreign” (nonself) [4] [5]. However, DNA 
viruses often evade the cytosolic detection machineries, as their genomes are not 
exposed until reaching the nucleus [4] [5]. The host counters this infection strategy 
in the nucleus by directly assembling supramolecular signaling platforms that 
trigger inflammatory responses on invading foreign DNA, but not on its own 
genomic material [6] [7] [8]. Although key players that target foreign dsDNA in the 
host nucleus have been identified [4] [5], the molecular mechanisms by which these 
sensors distinguish self from nonself dsDNA remain unknown.  
The interferon-inducible protein 16 (IFI16) is a key innate immune sensor 
that detects foreign dsDNA and uses it as a scaffold to assemble supra-molecular 
signaling platforms in both the host nucleus and cytoplasm [6] [7] [8] [9] [10]  
(Figure 4.1). IFI16 plays a central role in defense against a number of pathogens 
(e.g., herpes simplex virus-1) [6] [7] [8] [9] [10] ; on the other hand, persistent IFI16 
signaling is associated with autoimmunity (e.g. Sjögren’s syndrome) [11] [12] [13] 
[14] [15]. The molecular mechanisms by which IFI16 selectively targets foreign 
dsDNA remain unknown. To establish a functional signaling platform, IFI16 must 
overcome two challenges. First, individual IFI16 molecules must be able to locate 
one another on large pathogen genomes with sizes ranging from 105 to 106 base 
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pairs (bps).  Second and more importantly, this assembly mechanism can only take 
place on foreign dsDNA and must be inhibited on host dsDNA (Figure 4.1). Here, a 
unifying molecular mechanism that explains how IFI16 resolves these central issues 






















Figure 4.1: A simplified picture of the path of IFI16. Top: IFI16 is composed of 
three functional domains, namely one pyrin domain (PYD) and two dsDNA-binding 
Hin domains (HinA and HinB; Hin: hematopoietic interferon inducible nuclear 
antigen). flanked by unstructured regions.  Bottom: IFI16 is found in both the 
cytoplasm and nucleus, where it exhibits differentiated responses to viruses 














4.2.1. IFI16 Length-Dependent Assembly Kinetics Suggests 1D Diffusion 
To identify the mechanisms underlying assembly of IFI16 signaling platforms 
on DNA, the oligomerization kinetics of FRET donor and acceptor labeled IFI16 on 
naked dsDNA (FRET: Förster resonance energy transfer; Figure 4.2 and Table 4.1) 
was monitored. Chapter 2 demonstrated the existence of such oligomers and 
reported on their equilibrium binding properties, but did not provide insights into 
the assembly mechanisms. Using various dsDNA fragment sizes present in excess, 
the assembly rate increased non-linearly and by 50-fold from 60 to 200 bps dsDNA, 
above which it stayed constant (up to 600 bps; Figure 4.2A, Figure 4.2B). With a 
dsDNA-binding footprint of ~15 bp for one IFI16 (see Chapter 2), these results 
indicate that about four copies are required to initiate assembly, and about ten IFI16 
molecules are required for optimal oligomeric assembly (Figure 4.2B). Further, the 
assembly rate constants scaled linearly with the IFI16 concentration for all 
measured DNA lengths (Table 4.1), indicating that a purely cooperative assembly 
mechanism is unlikely. In line with this, Chapter 2 showed relatively small 
contributions of cooperativity in oligomerization with Hill constants near 2 for DNA 
substrates  up to 2000 bp.   
These observations of the faster assembly on longer dsDNA suggest a model 
in which IFI16 scans along dsDNA to increase the probability of encountering other 
IFI16 molecules (Figure 4.3).  The 1D diffusion of IFI16 on dsDNA explains why the 
assembly rates increase with the DNA length in the bulk experiments (Figure 4.2B).  
With the longer dsDNA acting as an antenna, it allows binding of more IFI16 while 
 119 
1D diffusion facilitates dynamic association (Figure 4.2B). The saturation of the 
assembly rate (Figure 4.2B) can be explained by the square dependence of the 
diffusional search time on length: at a sufficiently long dsDNA length, the 
dissociation rate of an individual IFI16 will be faster than the time needed to scan 
along the entire length of the DNA.  Overall, the results of these experiments are 
consistent with the dsDNA-size dependent binding in vitro (see Chapter 2), which 
also correlates with the IFI16-induced inflammatory responses in vivo [9]. Thus, it is 
proposed that the 1D-diffusion mediated assembly plays a key role in regulating the 

















Figure 4.2:  IFI16 assembles faster on longer dsDNA.  (A) Top: a cartoon scheme 
for FRET experiments.  The two differentially colored ovals represent fluorescently 
(DyLight-550 and DyLight-650) labeled IFI16.  Bottom: The time-dependent 
changes in the emission ratio between FRET donor and acceptor labeled IFI16 (50 
nM) were monitored at 33 μg/mL of each dsDNA (e.g., 6-fold higher than the 
dissociation constant for 39-bp dsDNA [see Chapter 2]).  Lines are fits to a first-
order exponential equation.  All shown representative experiments were performed 
at least three times.  (B) A plot of observed assembly rates (kassm) vs. dsDNA sizes 




Figure 4.3: A 1D-diffusion assisted assembly mechanism can explain the 
observed assembly profile of IFI16.  (A) At the same mass-concentrations the 
number of individual dsDNA fragments present in each assay is inversely 
proportional to the length of dsDNA.  (B) Individual IFI16 molecules initially bind 
dsDNA at random positions and diffuse one-dimensionally while searching for other 
respective protomers; the number of IFI16 molecules residing on the same dsDNA 
fragment should be proportional to the length of dsDN (e.g., there are four times 
more individual 150-bp fragments than 600-bp fragments).  (C) IFI16 fails to 
assemble into an oligomer on dsDNA shorter than 60 bp (indicated by a red arrow 
pointing up).  The saturating rates can be explained if the final FRET signals arise 




dsDNA size (bps) 25 nM IFI16 (sec
-1
) 50 nM IFI16 (sec
-1
) 
60  0.0004 ± 0.0002 0.0009 ± 0.0002 
70  0.0008 ± 0.0002 0.0021 ± 0.0008 
100  0.0052 ± 0.0008 0.012 ± 0.005 
150 0.019 ± 0.004 0.037 ± 0.008 
200 0.021 ± 0.007 0.049 ± 0.011 
300 0.029 ± 0.008 0.045 ± 0.014 
600 0.021 ± 0.008 0.043 ± 0.012 
Table 4.1: dsDNA-mediated oligomerization rates of FRET-labeled IFI16. Each 
experiment was performed at least three times and errors were calculated by using the 

















4.2.2. Chromatinization of DNA Inhibits IFI16 Cluster Formation 
It has long been speculated that chromatinization acts as the key feature that 
allows IFI16 to distinguish host from foreign DNA in the nucleus [6] [7] [8] [10] [16] 
[17]; IFI16 oligomerizes on exposed invading foreign-dsDNA before it becomes 
hetero-chromatinized. A previous in vivo work has demonstrated that pre-
chromatinized invading SV40 DNA is able to evade IFI16 oligomerization and 
downstream responses [16]. Nevertheless, the molecular mechanism by which 
IFI16 could use chromatinization to distinguish self from nonself has yet to be 
identified. To directly address this issue, a competition-binding assay was used to 
investigate how IFI16 interacts with dsDNA fragments containing two nucleosomes 
with varying spacer sizes (6, 30, 50, and 70 bps; Figure 4.4A). Here, di-nucleosomes 
with 6-, 30-, and 50-bp spacer failed to compete against IFI16-bound FAM-labeled 
70-bp dsDNA, (Figure 4.4B). On the other hand, the di-nucleosome with 70-bp 
spacer competed similarly as 70-bp naked dsDNA, but significantly more weakly 
than naked 300-bp dsDNA (Figure 3B). In FRET assembly assays, di-nucleosomes 
with spacers shorter than 70-bp failed to support assembly (Figure 3C), consistent 
with the FRET kinetics assays using naked dsDNA (Figure 4.2A,B). The 70-bp 
spacer di-nucleosome supported oligomerization of IFI16; however, the assembly 
kinetics was again similar to that of naked 70-bp dsDNA, but not that of naked 300-
bp dsDNA (Figure 4.4C). Taken together, these results show that efficient IFI16 
cluster formation requires a minimal length of 50-70 base pairs of exposed dsDNA. 
Considering that the size of dsDNA linker between two nucleosomes is about 20 to 
30 bps in mammals [18], these results directly support the hypothesis that 
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chromatinization is a key deterrent for preventing the assembly of IFI16 signaling 
























Figure 4.4:  Nucleosomes inhibit oligomerization.  (A) A cartoon of di-
nucleosome constructs with varying dsDNA spacers.  (B) Competition binding 
assays using IFI16 bound FAM-lebeled 70-bp dsDNA against various di-nucleosomes 
and naked dsDNA.  The lines are fits to: 1/(1+([DNAcompetitor]/IC50)^Hill Coefficient), 
where IC50 indicates the concentration of competitor at 50% efficiency.  The mass-
concentration of each competitor was calculated using dsDNA, but not histones.  (C) 
The time-dependent changes in the emission ratio between the FRET donor and 
acceptor labeled IFI16 (50 nM) were monitored at 33 μg/mL of each nucleosome or 




The molecular mechanism by which innate immune sensors distinguish self 
from foreign dsDNA in the host nucleus has been a major unresolved question in 
innate immunology [6] [7] [8] [10] [16] [17] [19]. The oligomerization of IFI16 on 
under-chromatinized foreign DNA plays a key role not only in initiating 
inflammatory and antiviral responses [8] [10] [20],, but also in regulating the 
hetero-chromatinization and silencing of viral dsDNA [16] [21]. By using time-
resolved bulk fluorescence assays, it is demonstrated here that IFI16 scans one-
dimensionally along exposed dsDNA to assemble, and that chromatinization is 
sufficient to inhibit IFI16 from targeting host dsDNA for assembly.  While this 
clustering on dsDNA presents a tempting explanation for IFI16’s role in viral gene 
silencing, future in vivo experiments await to test this. IFI16 belongs to the family of 
AIM2-like receptors, which include other nuclear and cytosolic foreign dsDNA-
sensors. It will be interesting to determine whether and how these other related 
sensors use exposed dsDNA as a 1D “digital ruler” to regulate their signaling 
platform assembly.   This family of sensors is implicated in a number of autoimmune 
disorders [11] [12] [13] [14] [15]; how regulation of assembly is disrupted may 









4.4.1 Protein Expression and Purification 
Full-length human IFI16 was cloned and expressed using E. Coli T7 express 
cells (NEB) as a C-terminally His6-tagged protein as described in Chapter 2. 
4.4.2 DNA Ligand Preparation 
dsDNA shorter than 90-bp were obtained from Integrated DNA Technologies 
(IDT) and are the same ligands as listed in Chapter 2.  The complementary strands 
were dissolved and mixed in 1:1 molar ratio, melted at 95°C for 10min, and the 
temperature was lowered to 25°C at a rate of 1°C/min.  Ligands of greater length 
were obtained by polymerase-chain reaction (PCR) using the Maltose Binding 
Protein fusion tag cloning sequence as template and primers of appropriate 
sequence for a final length as indicated in the assays.  Plasmids containing the 
Widom-601/603 sequence with indicated linker lengths were a kind gift of Dr. 
Gregory Bowman.  The nucleosomal DNA was obtained by PCR from these 
constructs with appropriate primers.  All ligands were gel-purified. 
4.4.3 Fluorescent Labeling 
DyLight-550 or DyLight-650, was incorporated to IFI16 using maleimide 
chemistry (purchased from Thermo Scientific and Invitrogen) and was performed as 
described in Chapter 2.  Fluorescein-labeled dsDNA72 was obtained from IDT. 
4.4.4 Octamer Refolding and Nucleosome Reconstitution 
Lyophylized Xenopus laevis histones H1A, H2A, H3, and H4 were a kind gift of 
Dr. Cynthia Wolberger.  Octamer refolding and nucleosome reconstitution was 
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performed as described in Luger et al. [22], at a 2:1 molar ratio of octamer:DNA. An 
agarose gel of reconstituted nucleosomes is shown in Figure 4.5.  
4.4.5 Biochemical Assays 
All absorption, fluorescence anisotropy, and fluorescence 
excitation/emission experiments were performed in a Tecan Infinite M1000.  All 
experiments were performed at least three times and the fits to data were generated 
by Kaleidagraph software (synergy). 
4.4.6 Competition Binding Assays 
All reactions were performed in 40 mM HEPES pH 7.4, 160 mM KCl, 5% 
glycerol, 1 mM EDTA, 0.1% triton-X-100, 5 mM DTT (Reaction Buffer).  300 nM 
IFI16 and 4.5 nM fluorescein-labeled dsVACV72 were incubated together at room 
temperature for 20min.  Increasing concentrations of competing DNA were added to 
the reaction to a final concentration of 100nM IFI16 and 1.5nM dsVACV72, and the 
changes in fluorescence anisotropy were recorded as indicated in Chapter 2. 
4.4.7 FRET Time Dependence Assays 
All reactions were performed in Reaction Buffer.  66 µg/ml of each dsDNA or 
di-nucleosomes was placed in the plate wells, and the reaction was initiated by 
adding an equivalent volume of IFI16-550 and IFI16-650 (1:1 molar ratio) to the 
indicated final concentration. The dead time between addition of IFI16 and the first 
measurement was 15-20s.  The final dsDNA molar-concentrations are at least 6-fold 
higher than their determined binding constants by fluorescence anisotropy assays 
described in Chapter 2, and the FRET ratio for each time point was calculated by 




Figure 4.5: Agarose gels with nucleosome preparations. Purified di-nucleosomes 
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The results of the experiments described in this thesis build a current picture 
of how ALRs recognize DNA, and how this may propagate further downstream to 
the next components of the signaling pathway.  As described in Chapter 2 and 
Chapter 3, IFI16 and AIM2 both bind dsDNA in a length-dependent manner that 
shows two-state behavior in solution assays.  This binding of DNA is coupled to 
assembly of a filament along the length of the DNA: disruption of the filament-
forming activity results in disruption of DNA-binding, and vice versa.  This DNA-
binding/self-oligomerization is in large part dictated by the N-terminal pyrin 
domain, as mutations in the PYD – which makes no interactions with DNA – in turn 
can lead to disruptions of DNA binding and loss of two-state, cooperative behavior.  
From these results, a revision of the old model of ALR activation is proposed.  The 
old model put forth a picture of ALRs existing in a state of autoinhibition before 
binding to DNA; DNA beyond the footprint of the ALR ought to relieve this 
autoinhibition.  As the main candidate for this autoinhibition model is an acidic 
patch on the face of AIM2-PYD, this was targeted for mutagenesis and found to 
result not in hyperactivation as would be predicted from an autoinhibition model 
but in a weakly binding protein that resembled the isolated HIN200 domain under 
imaging.  Length-dependent assembly of a filament upon DNA is a simpler, sufficient 
explanation of activation. 
   The length-dependency of DNA binding in turn suggests an answer to the 
problem of how these sensors distinguish self- from non-self DNA, which was 
addressed in Chapter 3.  As self-DNA is, under normal conditions, sequestered in the 
nucleus and blocked by various DNA-binding proteins as well as nucleosomes, long 
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stretches of naked DNA should be relatively uncommon.  Invading pathogenic will 
be exposed upon introduction to the cytoplasm or nucleus before it undergoes 
transcription or translation, giving a window of time in which these sensors may 
bind and form filaments upon the naked DNA.  A prediction of this model is that 
DNA protected by DNA-binding proteins – for instance, nucleosomes – should 
inhibit or prevent ALR oligomerization and DNA binding.  This was demonstrated by 
competition experiments that showed weakened binding to dinucleosomes with 
varying linker lengths, as well as reduced or abolished time-dependent 
oligomerization on them.  Thus, nucleosomes, abundant on self-DNA, ought to serve 
as barriers to self-recognition by ALRs. 
As to the question of how these sensors feed into the larger pathway of 
inflammasome activation and innate immune signaling, the results only address one 
of the two ALRs investigated.  For the case of AIM2, the symmetry of the filament 
matches that of the downstream effector ASC, suggesting that AIM2 may act as a 
nucleator/template for the polymerization of ASC.  This is especially attractive, as 
similar innate immune systems have demonstrated such behavior, and ASC has been 
shown to enhance its own oligomerization activity upon introduction of AIM2-DNA 
complexes.  However, there are many outstanding questions in regards to the 
joining of the sensing portion of the pathway to the later portions.  For instance, 
whether and how IFI16 is able to activate its own downstream effectors remains to 
be shown, and to date the symmetry of the IFI16 filament has not been determined.  
Also, whether symmetry is a necessary and/or sufficient means of templating ASC 
still has to be tested.  Thus the results of this thesis raise important questions that 
 136 
must be tested to determine whether symmetry and templating play large roles, and 
if so, whether it is a mechanism unique to the AIM2-ASC system or if it is a feature 
shared by all ALRs. 
 
